Vitamin deficiency

E4_VIT_DEF

ascorbic acid deficiency: A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into scurvy in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177)

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E50, E51, E52, E52+F02.89, E53, E54, E55, E56 Cause of death: ICD-10 — E50, E51, E52, E52+F02.89, E53, E54, E55, E56 2 out of 7 registries used, show all original rules.	1715
4. Check minimum number of events None	1715
5. Include endpoints E4_VIT_A_DEF E4_THIA_DEF E4_NIAC_DEF E4_VIT_B_DEF E4_VIT_C_DEF E4_VIT_D_DEF E4_VIT_E_DEF E4_VIT_K_DEF E4_VIT_NAS_DEF	2267
6. Filter based on genotype QC (FinnGen only)	1991

Control definitions (FinnGen only)

Control exclude: E4_NUTRIDEF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_VIT_DEF
CONTROL_EXCLUDE	E4_NUTRIDEF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_VIT_A_DEF\|E4_THIA_DEF\|E4_NIAC_DEF\|E4_VIT_B_DEF\|E4_VIT_C_DEF\|E4_VIT_D_DEF\|E4_VIT_E_DEF\|E4_VIT_K_DEF\|E4_VIT_NAS_DEF
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E5[0-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E5[0-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vitamin deficiency based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1991	1159	832
Unadjusted period prevalence (%)	0.40	0.41	0.38
Median age at first event (years)	57.21	52.77	63.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2094: Matched controls
20940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

384.5

307.7

641

B81

ICPC

Anaemia vit B12/folate deficiency

18.7

307.7

456

307

107

Kela drug reimbursment

Pernicious anaemia

49.8

307.7

467

120

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

243.3

307.7

442

B03BA03

ATC

hydroxocobalamin; parenteral

19.1

307.7

682

516

E66.8

ICD-10 Finland

Other obesity

25.7

232.4

164

K29.4

ICD-10 Finland

Chronic atrophic gastritis

12.6

189.0

191

165

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

184.0

962

3926

E51.2

ICD-10 Finland

Wernicke encephalopathy

1991.5

181.9

174

E66.01

ICD-10 Finland

Obesity due to excess calories

7.7

155.3

230

329

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

16.2

136.8

118

E66.9

ICD-10 Finland

Obesity, unspecified

18.6

128.4

103

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

26.4

106.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.9

94.7

319

931

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

93.7

906

4787

E50.9

ICD-10 Finland

Vitamin A deficiency, unspecified

+∞

89.2

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.3

88.7

248

631

T91

ICPC

Vitamin/nutritional deficiency

13.9

83.8

WVA30, ,

SPAT

4.0

78.0

241

658

E66.00

ICD-10 Finland

Metabolic syndrome

7.3

73.7

110

157

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

+∞

72.3

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

71.9

350

1278

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.2

69.2

150

309

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

65.7

512

2377

AA1AD

NOMESCO Finland

CT of head and brain

2.2

59.5

725

4057

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

57.2

1078

7091

E53.9

ICD-10 Finland

Vitamin B deficiency, unspecified

81.3

56.3

C03CA01

ATC

furosemide; systemic

2.1

54.8

732

4219

N05AH04

ATC

quetiapine; oral

2.4

52.8

463

2244

H03AA01

ATC

levothyroxine sodium; systemic

2.2

52.7

575

3054

E55

ICD-10 Finland

Vitamin D deficiency

20.9

51.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

51.0

352

1527

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.6

49.6

127

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

48.0

539

2880

SPAT1254

SPAT

Administration of medicine

2.4

46.9

390

1838

A02BC02

ATC

pantoprazole; systemic

2.0

46.8

1467

11207

E83.51

ICD-10 Finland

Hypocalcemia

12.8

46.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

45.7

355

1621

RD210, ,

NOMESCO Finland

6.8

45.1

107

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

45.1

258

1016

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

9.5

44.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

44.5

838

5369

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

44.3

367

1723

P15

ICPC

Chronic alcohol abuse

4.7

44.2

106

237

B03BA02

ATC

cyanocobalamin tannin complex; parenteral

13.0

42.6

N06AX11

ATC

mirtazapine; oral

1.9

42.5

779

4928

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

8.3

42.4

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

9.8

42.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

42.2

328

1495

N06AX16

ATC

venlafaxine; oral

2.4

42.1

350

1644

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

41.3

513

2828

N03AX16

ATC

[U] pregabalin

2.1

41.1

520

2887

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.1

41.0

116

295

N06AB04

ATC

citalopram; systemic

2.1

41.0

481

2596

B03BA01

ATC

cyanocobalamin; nasal, systemic

92.0

40.9

A10AE04

ATC

insulin glargine; parenteral

2.7

40.6

242

971

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

40.4

319

1463

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

40.3

737

4640

N02AX02

ATC

tramadol; systemic, rectal

1.9

40.1

917

6196

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

10.4

38.7

R4190

NOMESCO Finland

Nutritional therapy

3.9

38.6

118

317

UJF32

NOMESCO Finland

Coloscopy

2.0

38.5

586

3461

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

37.1

393

2031

R11

ICD-10 Finland

Nausea and vomiting

2.5

37.1

247

1045

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

36.9

308

1443

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

36.9

148

476

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

36.7

241

1012

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

36.7

564

3334

L28

ICPC

Limited function/disability (L)

2.1

36.6

454

2489

A10AB05

ATC

insulin aspart; parenteral

2.8

36.4

198

757

A28

ICPC

Limited function/disability NOS

2.1

35.9

434

2355

E50.0

ICD-10 Finland

Vitamin A deficiency with conjunctival xerosis

+∞

35.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

35.4

281

1287

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

35.2

517

3003

E56.8

ICD-10 Finland

Deficiency of other vitamins

353.0

35.0

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.7

34.7

117

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

34.0

436

2412

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

34.0

497

2878

E86

ICD-10 Finland

Volume depletion

4.3

33.6

215

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.7

33.5

170

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

33.1

121

367

C10AC01

ATC

colestyramine; oral

4.1

33.0

227

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

32.6

839

5773

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.9

32.5

103

A01

ICPC

Pain general/multiple sites

2.3

32.4

262

1208

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.3

32.1

201

L04AX01

ATC

azathioprine; systemic

3.4

32.1

119

364

SPAT1262

SPAT

Handing over of treatment supplies

2.1

31.6

361

1910

A11CC03

ATC

alfacalcidol; systemic

4.3

31.4

196

WVA20, ,

SPAT

3.4

31.4

115

349

2680A

ICD-9 Finland

Vitamin D deficiency, Rickets, active

+∞

31.3

A55

ICPC

General and Unspecified, Local injection/infiltration

6.4

30.8

E55.0

ICD-10 Finland

Rickets, active

+∞

30.3

A06AD11

ATC

lactulose; oral

2.0

30.2

357

1910

H02AB06

ATC

prednisolone; systemic

1.7

30.1

986

7203

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

30.1

118

374

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.3

29.2

112

350

E87.6

ICD-10 Finland

Hypokalaemia

3.4

29.2

106

320

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

29.1

222

996

T82

ICPC

Obesity

3.9

28.8

223

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

28.6

503

3071

-50

ICPC

Medication/prescr/renewal

3.2

28.5

118

386

N06AX21

ATC

duloxetine; oral

2.2

28.0

272

1350

SPAT1229

SPAT

Assessment of need for aid

2.5

27.8

180

748

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.9

27.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

27.6

162

642

N03AX12

ATC

[U] gabapentin; oral

2.0

27.6

349

1909

D51

ICD-10 Finland

Vitamin B12deficiency anaemia

11.3

27.6

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.3

27.5

109

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

27.3

269

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

27.0

116

388

C03DA01

ATC

spironolactone; oral

2.1

26.8

272

1371

376

Kela drug reimbursment

Cyanocobalamin

76.2

26.8

E66.0

ICD-10 Finland

Obesity due to excess calories

274.5

26.8

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

274.5

26.8

B80

ICPC

Iron deficiency anaemia

3.8

26.8

230

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.6

26.3

261

R53

ICD-10 Finland

Malaise and fatigue

1.7

26.3

575

3730

N05AX08

ATC

risperidone; systemic

2.3

26.1

219

1022

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

26.1

366

2072

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.3

26.0

201

906

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

10.1

25.6

SPAT1216

SPAT

Assessment of functional ability

2.0

25.6

338

1874

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

25.6

306

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

5.5

25.3

N05AH03

ATC

olanzapine; systemic

2.5

25.2

161

665

R06.0

ICD-10 Finland

Dyspnoea

1.7

25.0

566

3701

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

24.8

305

1648

A10BA02

ATC

metformin; oral

1.7

24.8

540

3491

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.6

24.8

ZX120

NOMESCO Finland

Intravenous

2.2

24.5

219

1048

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.3

24.5

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.2

24.4

158

SPAT1255

SPAT

Intravenous administration of medicine

2.5

24.4

157

651

N07BB01

ATC

disulfiram; oral

3.1

24.3

102

337

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

24.2

236

1169

N06AB10

ATC

escitalopram; oral

1.8

24.2

426

2586

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

24.2

223

1081

ZXD05

NOMESCO Finland

Urgent procedure

1.7

23.9

620

4194

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.2

23.9

319

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.5

23.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

23.7

569

3769

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.8

23.7

R50.9

ICD-10 Finland

Fever, unspecified

1.9

23.6

341

1944

T90

ICPC

Diabetes non-insulin dependent

1.8

23.6

453

2819

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

23.6

110

386

K70.0

ICD-10 Finland

Alcoholic fatty liver

9.4

23.5

R51.80

ICD-10 Finland

Headache

1.9

23.5

353

2038

J01MA12

ATC

levofloxacin; systemic

1.8

23.5

384

2278

N05AA02

ATC

levomepromazine; systemic

3.1

23.4

102

344

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

23.4

130

501

N03AG01

ATC

valproic acid; systemic, rectal

2.5

23.1

146

600

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.6

23.1

220

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

23.1

218

1067

N02AA05

ATC

oxycodone; systemic

1.8

23.1

395

2375

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

22.9

384

2293

A04

ICPC

Weakness/tiredness general

1.8

22.8

369

2180

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

22.8

165

722

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

22.8

148

616

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

22.7

327

1860

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

22.6

756

5437

SPAT1263

SPAT

Sampling

1.6

22.5

830

6108

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

22.3

190

891

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

22.3

119

449

SPAT1240

SPAT

Therapeutic discussion

2.1

22.2

225

1131

N06AB03

ATC

fluoxetine; oral

2.0

22.1

261

1388

26500

ICD-8 Finland

Vitamin D deficiency, Rickets active

+∞

21.9

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.7

21.9

199

UJF92

NOMESCO Finland

Capsular endoscopy

3.9

21.7

168

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

21.7

157

687

J01MA02

ATC

ciprofloxacin; systemic

1.6

21.6

767

5580

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.9

21.6

ZY010

NOMESCO Finland

Hospital outpatient

2.6

21.5

132

534

R42

ICD-10 Finland

Dizziness and giddiness

1.7

21.4

484

3145

SPAT1301

SPAT

No procedures

1.6

21.2

625

4345

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

21.2

385

2351

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.7

21.0

181

N02BE01

ATC

paracetamol; systemic, rectal

1.9

21.0

1809

16184

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

21.0

237

1239

F10.24

ICD-10 Finland

Alcohol depence active use

4.5

20.9

116

A12AA04

ATC

calcium carbonate; oral

4.5

20.8

112

SPAT1172

SPAT

Guidance concerning hydration

3.7

20.7

178

A10AC01

ATC

insulin (human); parenteral

2.3

20.7

169

778

N05BA04

ATC

oxazepam; oral

1.7

20.7

539

3630

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.6

20.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

20.4

294

1670

K08.3

ICD-10 Finland

Retained dental root

2.2

20.4

175

823

K50.8

ICD-10 Finland

Other Crohn disease

4.6

20.4

106

P01AB01

ATC

metronidazole; oral, rectal

1.6

20.3

776

5721

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

20.3

394

2449

N05CF01

ATC

zopiclone; oral

1.6

20.2

648

4587

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

20.2

308

1782

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

20.1

843

6341

N03AX09

ATC

lamotrigine; oral

2.7

20.1

111

426

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

20.0

320

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

19.9

553

3780

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

19.8

E51.9

ICD-10 Finland

Thiamine deficiency, unspecified

+∞

19.8

N06AA09

ATC

amitriptyline; systemic

2.1

19.8

200

1003

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.3

19.8

121

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

3.7

19.8

170

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

19.7

564

3880

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

19.6

118

473

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

5.2

19.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

19.6

186

911

F05.9

ICD-10 Finland

Delirium, unspecified

3.6

19.5

186

R60.0

ICD-10 Finland

Localized oedema

1.9

19.4

260

1441

B82

ICPC

Anaemia other/unspecified

3.1

19.4

272

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

19.4

138

599

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

19.3

158

729

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.0

19.3

141

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.9

19.2

K92.1

ICD-10 Finland

Melaena

2.4

19.2

130

552

J01FF01

ATC

clindamycin; systemic

1.6

19.1

525

3572

TAB00

NOMESCO Finland

Lumbar puncture

2.6

19.0

112

445

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

55.5

18.9

M79.6

ICD-10 Finland

Pain in limb

1.5

18.9

865

6608

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.1

18.9

271

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

5.1

18.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

18.8

325

1949

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

18.8

142

632

2662A

ICD-9 Finland

Deficiency of B-complex components, Other B-complex deficiencies[HYPOVITAMINOSIS B12]

+∞

18.8

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

18.8

222

1179

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

18.7

804

6056

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

18.6

263

1482

M81.8

ICD-10 Finland

Other osteoporosis

5.4

18.6

104

Kela drug reimbursment

Thyroid insufficiency

2.2

18.5

160

754

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.2

18.4

119

B01AB05

ATC

enoxaparin; parenteral

1.6

18.4

588

4141

SPAT1310

SPAT

Counselling related to known health issue

1.6

18.3

603

4276

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

18.3

107

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.9

18.3

N05BA01

ATC

diazepam; systemic, rectal

1.9

18.2

268

1531

N03AE01

ATC

clonazepam; systemic

2.4

18.0

127

549

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

18.0

211

N05CD07

ATC

temazepam; oral

1.9

17.9

247

1382

Z3231

NOMESCO Finland

Registered nurse

1.6

17.8

537

3726

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

17.8

359

A07AA02

ATC

nystatin; oral

2.4

17.8

130

571

N02BF02

ATC

pregabalin; oral

2.2

17.7

147

682

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

17.6

232

1277

EBA00

NOMESCO Finland

Extraction of tooth

1.5

17.5

715

5306

C07AB07

ATC

bisoprolol; oral

1.5

17.5

932

7310

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.8

17.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

17.4

159

767

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

17.3

103

411

A46

ICD-10 Finland

Erysipelas

1.8

17.2

285

1685

A05AA02

ATC

ursodeoxycholic acid; oral

4.0

17.2

121

P03

ICPC

Feeling depressed

2.0

17.1

208

1115

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

17.0

220

1204

R52.2

ICD-10 Finland

Other chronic pain

2.7

17.0

356

SPAT1260

SPAT

Consultation of another employee

1.7

17.0

341

2132

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.9

489

3355

QBJ30

NOMESCO Finland

Correction of abdominal apron

19.4

16.9

D51.8

ICD-10 Finland

Other vitamin B12deficiency anaemias

19.4

16.9

P29

ICPC

Psychological sympt/compl other

2.1

16.9

164

810

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

16.8

119

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

16.7

317

1949

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

16.7

583

4173

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

16.7

377

2430

H02AB09

ATC

hydrocortisone; systemic

3.3

16.6

196

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

16.5

315

S97

ICPC

Chronic ulcer skin

2.3

16.5

135

622

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.1

16.5

A29

ICPC

General symptom/complaint other

1.8

16.4

284

1700

P76

ICPC

Depressive disorder

2.2

16.4

143

676

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

16.4

462

3147

E66

ICD-10 Finland

Obesity

2.7

16.3

340

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

16.3

114

491

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

16.3

154

J01DB01

ATC

cefalexin; oral

1.6

16.1

1640

14569

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

16.1

144

689

A10BH01

ATC

sitagliptin; oral

2.0

16.0

174

895

C07AA05

ATC

propranolol; systemic

1.6

16.0

396

2612

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

15.8

170

871

Z2445

NOMESCO Finland

Psychologist

2.6

15.8

369

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

15.7

355

2288

ZX114, ,

SPAT

4.1

15.6

103

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

15.6

264

1569

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

15.6

562

4041

T89

ICPC

Diabetes insulin dependent

2.6

15.6

366

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

15.6

224

1268

N18.8

ICD-10 Finland

Other chronic renal failure

3.3

15.5

174

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

15.5

126

580

A07EA06

ATC

budesonide; oral, local oral

2.6

15.4

339

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.9

15.2

114

UJD02

NOMESCO Finland

Gastroscopy

2.4

15.2

106

456

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

15.1

150

747

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.3

15.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

15.0

257

1533

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

14.9

113

504

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

14.9

107

466

N30.0

ICD-10 Finland

Acute cystitis

1.6

14.9

347

2250

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

14.9

1389

11991

N06AB06

ATC

sertraline; oral

1.8

14.8

233

1355

SPAT1211

SPAT

Application of soft bandage

2.0

14.8

178

950

N05AX12

ATC

aripiprazole; systemic

2.6

14.8

334

R10.0

ICD-10 Finland

Acute abdomen

2.8

14.7

277

P16

ICPC

Acute alcohol abuse

3.8

14.7

117

M04AA01

ATC

allopurinol; systemic

1.8

14.7

244

1442

NHQ40

NOMESCO Finland

Amputation of toe

3.9

14.7

108

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

14.7

732

5613

D01

ICPC

Abdominal pain/cramps general

1.8

14.7

257

1543

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

14.6

230

1337

E61.2

ICD-10 Finland

Magnesium deficiency

+∞

14.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

14.5

196

1087

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

14.5

230

1342

M54.5

ICD-10 Finland

Low back pain

1.5

14.4

695

5289

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

14.4

221

1276

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

14.4

114

519

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

14.3

155

796

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

14.3

236

JN4AD

NOMESCO Finland

Body CT examination

1.8

14.3

218

1255

L76

ICPC

Fracture: other

2.7

14.3

281

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

14.3

104

456

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

14.3

316

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

14.2

159

826

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.1

14.1

200

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

14.1

172

921

WVA20

NOMESCO Finland

Medicine administration

2.9

14.1

238

A02BC03

ATC

lansoprazole; oral

1.5

14.1

543

3947

M79.7

ICD-10 Finland

Fibromyalgia

2.7

14.1

295

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.1

14.1

185

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

6.7

14.0

G47.3

ICD-10 Finland

Sleep apnoea

1.6

14.0

374

2505

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.5

14.0

140

Z3226

NOMESCO Finland

Physiotherapist

1.6

14.0

350

2307

Z2446

NOMESCO Finland

Social worker

2.1

14.0

145

733

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.7

14.0

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.5

13.9

350

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

13.9

399

R55

ICD-10 Finland

Syncope and collapse

1.8

13.9

226

1327

SPAT1312

SPAT

General health counselling

1.5

13.8

580

4290

M35.7

ICD-10 Finland

Hypermobility syndrome

4.1

13.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.3

13.7

162

J46

ICD-10 Finland

Status asthmaticus

2.9

13.7

231

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

13.7

1110

9269

Z72.0

ICD-10 Finland

Tobacco use

3.0

13.6

199

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.4

13.6

148

E50.7

ICD-10 Finland

Other ocular manifestations of vitamin A deficiency

+∞

13.6

WX002

NOMESCO Finland

Sedation and analgesia

1.6

13.5

357

2383

-55

ICPC

Local injection/infiltration

5.5

13.5

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

13.5

278

L04AA06

ATC

mycophenolic acid; systemic

3.5

13.5

129

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.8

13.5

226

1338

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

13.5

115

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

13.4

320

R02

ICPC

Shortness of breath/dyspnoea

1.7

13.4

263

1628

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

13.4

375

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

13.3

388

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.5

13.3

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.5

13.3

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.3

13.3

150

ZX114

NOMESCO Finland

Intramuscular

3.8

13.3

107

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

13.2

217

1277

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

13.2

121

584

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.7

13.2

270

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

13.2

495

3573

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.1

993

8167

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

13.0

207

1206

JAH01

NOMESCO Finland

Laparoscopy

2.3

13.0

412

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.0

12.9

189

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.1

12.9

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

22.7

12.9

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

22.7

12.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

12.8

169

K70.4

ICD-10 Finland

Alcoholic hepatic failure

11.6

12.8

P99

ICPC

Psychological disorders other

2.7

12.8

257

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

12.8

134

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

12.7

129

647

S06.0

ICD-10 Finland

Concussion

1.8

12.7

220

1315

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.2

12.6

155

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

15.5

12.6

A07AA09

ATC

vancomycin; oral

3.9

12.5

Z72.1

ICD-10 Finland

Alcohol use

3.9

12.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

12.5

128

644

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

12.5

313

F02.89*E53.8

ICD-10 Finland

Dementia due to vitamin B12 deficiency

+∞

12.5

H02AB07

ATC

prednisone; oral

1.7

12.5

255

1594

W19

ICD-10 Finland

Unspecified fall

1.8

12.4

202

1185

N05AF03

ATC

chlorprothixene; systemic

3.1

12.4

167

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

12.4

134

688

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

12.4

216

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

12.4

149

795

K92.0

ICD-10 Finland

Haematemesis

2.9

12.4

205

K02.1

ICD-10 Finland

Caries of dentine

1.4

12.3

1102

9286

SPAT1167

SPAT

Insertion of urinary catheter

2.6

12.3

262

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

12.3

155

840

KH1AD

NOMESCO Finland

CT of urinary organs

2.6

12.3

286

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

12.3

300

1964

K07

ICPC

Swollen ankles/oedema

2.2

12.2

455

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

12.2

366

D09

ICPC

Nausea

2.2

12.2

104

488

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

12.2

432

3074

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

12.1

128

652

R03AC02

ATC

salbutamol; inhalant

1.4

12.1

1043

8724

Y94.0

ICD-10 Finland

Accident at home

3.1

12.1

159

D12

ICPC

Constipation

2.4

12.1

361

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

12.1

306

P01

ICPC

Feeling anxious/nervous/tense

1.7

12.1

248

1552

UKC02

NOMESCO Finland

Cystoscopy

1.6

12.0

294

1924

F61.0

ICD-10 Finland

Mixed personality disorders

3.8

12.0

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.1

12.0

160

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.5

12.0

115

L17

ICPC

Foot/toe symptom/complaint

1.4

12.0

568

4281

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

11.9

189

1100

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

11.9

129

664

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

11.8

435

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

11.8

113

555

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.4

11.8

121

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

11.8

487

3572

ZX120, ,

SPAT

3.8

11.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

11.7

128

660

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

11.7

370

2567

IGY02, ,

SPAT

3.5

11.7

112

H53.2

ICD-10 Finland

Diplopia

2.5

11.7

293

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

11.7

199

1183

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.5

11.7

117

A10AE05

ATC

insulin detemir; parenteral

2.2

11.7

464

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

16.5

11.7

F03

ICD-10 Finland

Unspecified dementia

2.2

11.6

100

471

E83.50

ICD-10 Finland

Hypercalcemia

3.8

11.6

R25.1

ICD-10 Finland

Tremor, unspecified

2.6

11.6

259

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

11.5

1001

8359

N03AF01

ATC

carbamazepine; oral, rectal

2.1

11.5

103

493

E51.8

ICD-10 Finland

Other manifestations of thiamine deficiency

+∞

11.5

G32.0*E53.8

ICD-10 Finland

Subacute combined degeneration of the spinal cord in case of vitamin B12 deficiency

+∞

11.5

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.4

11.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

11.4

158

882

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.5

11.4

WZC30

NOMESCO Finland

Teaching

1.6

11.4

301

2005

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

11.4

369

2574

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

11.4

340

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

11.4

115

577

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

11.4

469

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

11.9

11.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

11.3

112

558

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

10.6

11.3

SPAT1125

SPAT

Stoma care and guidance

3.4

11.3

115

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

11.2

146

799

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.3

11.2

380

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

11.2

848

6915

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

11.1

307

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

11.1

376

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

11.1

247

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

5.8

11.0

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

11.0

475

3509

M25.5

ICD-10 Finland

Pain in joint

1.4

11.0

612

4736

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

11.0

245

1566

R06AE07

ATC

cetirizine; oral

1.4

11.0

817

6638

H02AB04

ATC

methylprednisolone; systemic

1.6

11.0

260

1687

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

11.0

177

1036

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

11.0

191

1143

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.5

11.0

N03AX11

ATC

topiramate; oral

2.8

10.9

191

N06AX03

ATC

mianserin; oral

2.2

10.9

430

205

Kela drug reimbursment

Chronic hypertension

1.5

10.9

468

3455

N06AX12

ATC

bupropion; oral

1.9

10.8

132

708

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.7

10.8

215

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

10.8

417

3013

D50

ICD-10 Finland

Iron deficiency anaemia

2.8

10.8

187

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.9

10.7

SPAT1252

SPAT

Overall medication plan or its review

1.9

10.7

128

681

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

10.7

275

SPAT1234

SPAT

Support of social functional capacity

2.1

10.7

107

535

XG466

NOMESCO Finland

Sleep oxymetry

2.8

10.7

188

V03AG01

ATC

sodium cellulose phosphate; systemic

21.6

10.7

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

10.7

135

733

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

10.7

119

619

I95.9

ICD-10 Finland

Hypotension, unspecified

3.1

10.6

140

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

10.6

229

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

10.6

229

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.3

10.6

120

E000001, ,

ATC

1.5

10.6

363

2561

K65.0

ICD-10 Finland

Acute peritonitis

4.0

10.5

N05BA02

ATC

chlordiazepoxide; systemic

2.8

10.5

190

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

10.5

197

1204

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

10.5

138

759

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

10.5

179

127

Kela drug reimbursment

Transplant complication

3.5

10.5

101

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.0

10.4

152

K83.0

ICD-10 Finland

Cholangitis

3.4

10.4

106

E56.9

ICD-10 Finland

Vitamin deficiency, unspecified

110.6

10.4

RD130, ,

NOMESCO Finland

110.6

10.4

E83.30

ICD-10 Finland

Acid phosphatase deficiency

110.6

10.4

E56.0

ICD-10 Finland

Deficiency of vitamin E

+∞

10.4

26599

ICD-8 Finland

Vitamin D deficiency, Unspecified

+∞

10.4

26510

ICD-8 Finland

Vitamin D deficiency, Rickets, late effect

+∞

10.4

K90.0

ICD-10 Finland

Coeliac disease

2.5

10.4

273

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

10.4

158

R4110

NOMESCO Finland

Physiotherapy

1.4

10.4

506

3819

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

32.7

10.3

A10BB12

ATC

glimepiride; oral

1.9

10.3

126

676

N02BF01

ATC

gabapentin; oral

1.7

10.3

189

1147

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

10.3

148

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

10.3

168

987

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

10.3

223

1415

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.3

10.3

112

UJK02

NOMESCO Finland

ERCP

2.6

10.3

221

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.6

10.2

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

10.2

455

T74.1

ICD-10 Finland

Physical abuse

3.3

10.1

118

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.5

10.1

240

C07AB02

ATC

metoprolol; systemic

1.5

10.1

363

2582

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.2

10.1

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

10.1

365

A10BH05

ATC

linagliptin; oral

2.1

10.1

458

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

10.1

409

2981

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.5

10.1

247

A10BJ02

ATC

liraglutide; parenteral

3.0

10.0

140

JN4BD

NOMESCO Finland

Extensive body CT

1.7

10.0

185

1127

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

9.9

173

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.9

9.9

162

J01DA09

ATC

[U] cefadroxil

1.4

9.9

476

3578

SFA10

NOMESCO Finland

One-surface restoration

1.3

9.9

1013

8602

A02BC01

ATC

omeprazole; systemic

1.4

9.9

494

3739

S10

ICPC

Boil/carbuncle

2.0

9.9

112

586

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

9.9

180

1091

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

9.8

415

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

5.2

9.8

R5110, ,

SPAT

1.8

9.8

160

939

B02AA02

ATC

tranexamic acid; systemic

1.6

9.8

260

1731

K56.7

ICD-10 Finland

Ileus, unspecified

3.1

9.8

131

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

9.8

106

546

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.5

9.8

H03BB01

ATC

carbimazole; oral

2.2

9.8

390

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

9.7

121

653

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.7

629

4975

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

9.7

418

I50.0

ICD-10 Finland

Congestive heart failure

1.8

9.7

145

831

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

9.6

140

794

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

9.6

113

598

R51

ICD-10 Finland

Headache

1.9

9.6

112

591

F32

ICD-10 Finland

Depressive episode

2.0

9.6

101

514

C09AA02

ATC

enalapril; systemic

1.5

9.6

337

2384

F22.0

ICD-10 Finland

Delusional disorder

3.4

9.6

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.3

9.6

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

9.6

393

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

9.6

171

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

9.6

247

R4120

NOMESCO Finland

Occupational therapy

1.9

9.6

125

686

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

9.6

235

1537

D06

ICPC

Abdominal pain localized other

1.7

9.6

171

1031

3051, ,

Kela drug reimbursment

4.8

9.5

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

10.1

9.5

J01EA01

ATC

trimethoprim; systemic

1.4

9.5

480

3638

SPAT1104

SPAT

Monitoring of emergency patient

1.9

9.5

117

630

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

9.5

168

1010

N05BE01

ATC

buspirone; oral

2.5

9.5

242

J01DA01

ATC

[U] cefalexin

1.3

9.5

1155

10039

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.9

9.5

150

N03AX14

ATC

levetiracetam; systemic

2.5

9.4

237

S18

ICPC

Laceration/cut

1.3

9.4

853

7100

F40.2

ICD-10 Finland

Specific (isolated) phobias

5.2

9.4

ZY000

NOMESCO Finland

Hospital inpatient

3.4

9.3

WZC00, ,

SPAT

1.5

9.3

270

1834

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.7

9.3

K29.8

ICD-10 Finland

Duodenitis

4.7

9.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

9.3

365

D11

ICPC

Diarrhoea

1.6

9.3

222

1443

NH1AD

NOMESCO Finland

Ankle and foot CT

2.7

9.2

180

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

9.2

386

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

9.2

114

615

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.5

9.2

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.3

9.2

321

C08CA01

ATC

amlodipine; oral

1.4

9.2

666

5352

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

9.2

157

935

D10

ICPC

Vomiting

1.9

9.2

115

623

TPH04, ,

SPAT

3.7

9.2

M10.9

ICD-10 Finland

Gout, unspecified

1.9

9.1

121

668

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.0

9.1

137

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.0

9.1

R4140

NOMESCO Finland

Psychotherapy

5.0

9.1

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

9.1

342

D07AA02

ATC

hydrocortisone; topical

1.5

9.1

256

1728

SPAT1097

SPAT

Recording of ECG

1.6

9.1

241

1605

SPAT1053

SPAT

Memory test

1.6

9.1

246

1646

A02BC05

ATC

esomeprazole; systemic

1.3

9.0

726

5924

E87.2

ICD-10 Finland

Acidosis

7.1

9.0

E66.1

ICD-10 Finland

Drug-induced obesity

36.8

9.0

S22.3

ICD-10 Finland

Fracture of rib

1.8

9.0

140

811

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

8.9

327

2331

IHZ05, ,

SPAT

2.1

8.9

411

N17.8

ICD-10 Finland

Other acute renal failure

3.5

8.9

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

8.9

398

D52.0

ICD-10 Finland

Dietary folate deficiency anaemia

24.1

8.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

8.9

487

F34.1

ICD-10 Finland

Dysthymia

2.2

8.9

319

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

3.7

8.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

8.9

180

1122

L03

ICPC

Low back symptom/complaint

1.4

8.8

526

4093

J45.8

ICD-10 Finland

Mixed asthma

2.4

8.8

263

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

8.8

386

2849

E0000UV, ,

ATC

1.3

8.8

768

6339

A07AA11

ATC

rifaximin; oral

9.5

8.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

8.8

IHZ04, ,

SPAT

3.0

8.7

124

P20

ICPC

Memory disturbance

1.5

8.7

260

1776

OAB43, ,

SPAT

0.7

8.7

320

4365

N05AD01

ATC

haloperidol; systemic

2.3

8.7

290

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.3

8.7

265

R03BB04

ATC

tiotropium bromide; inhalant

1.6

8.7

182

1145

T83

ICPC

Overweight

2.8

8.7

152

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.3

8.7

D94

ICPC

Chronic enteritis/ulcerative colitis

4.3

8.7

N05BA12

ATC

alprazolam; oral

1.7

8.6

174

1083

G72.8

ICD-10 Finland

Other specified myopathies

3.0

8.6

125

R52.9

ICD-10 Finland

Pain, unspecified

1.6

8.6

187

1186

K59.0

ICD-10 Finland

Constipation

1.9

8.6

108

585

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.0

8.6

SPAT1360

SPAT

Extensive global examination

1.8

8.6

120

673

L14

ICPC

Leg/thigh symptom/complaint

1.7

8.6

152

914

JKA20

NOMESCO Finland

Cholecystectomy

2.5

8.6

217

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

8.5

126

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

8.5

194

L04AX03

ATC

methotrexate; systemic

1.7

8.5

173

1080

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

8.5

121

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

8.5

489

L95

ICPC

Osteoporosis

2.1

8.5

379

N19

ICD-10 Finland

Unspecified kidney failure

2.1

8.5

359

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

8.4

143

N06AB05

ATC

paroxetine; oral

1.9

8.4

101

539

L04AD02

ATC

tacrolimus; systemic

3.9

8.4

SPAT1244

SPAT

Occupational therapy

3.9

8.4

M83.9

ICD-10 Finland

Adult osteomalacia, unspecified

90.4

8.4

WX892

NOMESCO Finland

Monitored bed care

1.7

8.4

139

820

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.4

712

5842

D07AB08

ATC

desonide; topical

1.6

8.4

197

1275

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.4

257

JF1AD

NOMESCO Finland

Small bowel CT

4.7

8.4

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

8.3

144

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.3

307

2190

E56.1

ICD-10 Finland

Deficiency of vitamin K

+∞

8.3

E53.1

ICD-10 Finland

Pyridoxine deficiency

+∞

8.3

K04.08

ICD-10 Finland

Other specified pulpit

1.7

8.3

142

845

R96

ICPC

Asthma

1.7

8.3

170

1062

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.1

8.3

112

E61.1

ICD-10 Finland

Iron deficiency

2.6

8.3

185

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.1

8.3

107

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

8.3

125

719

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

8.2

162

1002

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

8.2

473

WX730

NOMESCO Finland

Conventional respirator

3.2

8.2

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

8.2

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.9

8.2

101

544

C09AA05

ATC

ramipril; oral

1.4

8.2

424

3217

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.1

8.2

384

JF1BD

NOMESCO Finland

Very extensive small bowel CT

6.5

8.2

I50.1

ICD-10 Finland

Left ventricular failure

2.0

8.2

481

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.7

8.2

A10BG03

ATC

pioglitazone; oral

2.7

8.1

163

Z50.1

ICD-10 Finland

Other physical therapy

1.9

8.1

510

WX704

NOMESCO Finland

Intubation

1.7

8.1

146

882

N29

ICPC

Neurological sympt/complt other

2.7

8.1

158

G44.2

ICD-10 Finland

Tension-type headache

1.5

8.1

242

1655

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

8.1

164

1024

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

8.1

106

584

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.1

8.0

373

K30

ICD-10 Finland

Functional dyspepsia

1.6

8.0

199

1304

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

8.0

347

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

8.0

415

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

8.0

436

A41.8

ICD-10 Finland

Other specified sepsis

2.8

8.0

142

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

8.0

210

1396

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.3

7.9

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

7.9

172

1091

OAA68, ,

SPAT

3.3

7.9

S70.0

ICD-10 Finland

Contusion of hip

2.0

7.9

389

ZXA05

NOMESCO Finland

Left side

1.4

7.9

421

3208

S29

ICPC

Skin symptom/complaint other

1.4

7.9

361

2679

SPAT1283

SPAT

Restricted health certificate

1.5

7.9

286

2032

Z00.0

ICD-10 Finland

General medical examination

1.4

7.9

349

2575

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

7.9

270

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

13.1

7.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

7.9

136

813

A03

ICPC

Fever

1.4

7.9

312

2257

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

7.9

363

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.9

140

844

N99

ICPC

Neurological disease other

3.2

7.8

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

3.4

7.8

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.4

7.8

P17

ICPC

Tobacco abuse

3.3

7.8

A10AE06

ATC

insulin degludec; parenteral

2.2

7.8

291

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

7.8

461

N07

ICPC

Convulsion/seizure

9.4

7.8

N05AN01

ATC

lithium; oral

2.6

7.8

173

D52.9

ICD-10 Finland

Folate deficiency anaemia, unspecified

7.0

7.8

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

7.0

7.8

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

7.8

285

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.8

7.8

133

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.8

234

P19

ICPC

Drug abuse

4.2

7.7

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.2

7.7

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

7.7

189

1235

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

15.1

7.7

M05BA04

ATC

alendronic acid; oral

1.6

7.7

157

981

R03DC03

ATC

montelukast; oral

1.5

7.7

291

2086

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.7

179

1157

TJF80

NOMESCO Finland

Ostomy education

3.7

7.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

7.6

381

JAH00

NOMESCO Finland

Laparotomy

2.3

7.6

236

A99

ICPC

Disease/condition unspecnature/site

1.6

7.6

195

1288

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

7.6

451

S02

ICPC

Pruritus

2.0

7.6

368

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.7

7.6

H25.8

ICD-10 Finland

Other senile cataract

1.6

7.6

189

1241

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.9

7.5

124

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

7.5

523

4154

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.1

7.5

B37.08

ICD-10 Finland

Other candidal stomatitis

3.8

7.5

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

7.5

140

854

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

7.5

111

634

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

7.5

182

N01

ICPC

Headache

1.5

7.5

212

1431

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

7.5

181

1179

WW200

NOMESCO Finland

Immunization

2.4

7.5

219

R03AC03

ATC

terbutaline; inhalant

1.5

7.5

239

1656

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

7.5

391

WW500

NOMESCO Finland

Blood transfusion

2.0

7.5

398

G35

ICD-10 Finland

Multiple sclerosis

2.9

7.4

114

P06

ICPC

Sleep disturbance

1.5

7.4

221

1508

X58

ICD-10 Finland

Exposure to other specified factors

1.5

7.4

263

1860

S01.0

ICD-10 Finland

Open wound of scalp

1.7

7.4

145

896

E83.3

ICD-10 Finland

Disorders of phosphorus metabolism and phosphatases

80.4

7.4

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.0

7.4

104

M48.0

ICD-10 Finland

Spinal stenosis

1.5

7.3

210

1421

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

7.3

160

1017

J01AA02

ATC

doxycycline; systemic

1.3

7.3

1443

13162

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.1

7.3

Z94.4

ICD-10 Finland

Liver transplant status

8.4

7.3

WX290

NOMESCO Finland

Other blockage of nerve

1.3

7.3

843

7177

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.3

501

3969

Z94.0

ICD-10 Finland

Kidney transplant status

3.6

7.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

7.3

428

3310

26000

ICD-8 Finland

Vitamin A deficiency, Night blindness

+∞

7.3

RD140, ,

NOMESCO Finland

+∞

7.3

26520

ICD-8 Finland

Vitamin D deficiency, Osteomalacia

+∞

7.3

R33

ICD-10 Finland

Retention of urine

1.7

7.3

142

877

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

9.4

7.3

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.6

7.3

161

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

7.3

173

R52.0

ICD-10 Finland

Acute pain

2.1

7.3

313

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

7.3

157

996

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.8

7.3

W01

ICPC

Question of pregnancy

4.3

7.2

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.8

7.2

C10AA01

ATC

simvastatin; oral

1.3

7.2

686

5692

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.0

7.2

100

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.9

7.2

111

R13

ICD-10 Finland

Dysphagia

1.7

7.1

132

804

A01AB09

ATC

miconazole; local oral

1.6

7.1

155

984

EB1VA, ,

NOMESCO Finland

1.4

7.1

297

2166

R5599

NOMESCO Finland

Other rehabilitation service

2.2

7.1

269

L04AA01

ATC

[U] ciclosporin

3.3

7.1

ZXA00

NOMESCO Finland

Right side

1.4

7.1

453

3548

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

7.1

243

1708

N03AF02

ATC

oxcarbazepine; oral

2.2

7.1

283

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

7.1

237

1658

UJF02

NOMESCO Finland

Peroral enteroscopy

6.0

7.1

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

7.0

214

1467

R4180

NOMESCO Finland

Podiatric therapy

3.0

7.0

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

7.0

219

-, ,

ICD-10 Finland

2.4

7.0

188

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

7.0

110

640

SFA30

NOMESCO Finland

Three-surface restoration

1.3

7.0

724

6067

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.1

7.0

SPAT1127

SPAT

Enema

4.2

7.0

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

7.0

105

603

E21.2

ICD-10 Finland

Other hyperparathyroidism

7.0

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.9

7.0

TK800

NOMESCO Finland

Hemodialysis

2.7

7.0

141

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.2

7.0

239

L85.3

ICD-10 Finland

Xerosis cutis

3.2

7.0

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.2

7.0

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

7.0

167

1086

JFF10

NOMESCO Finland

Loop enterostomy

4.4

7.0

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.0

305

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

6.9

165

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

6.9

165

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

6.3

6.9

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.9

141

881

C03AA03

ATC

hydrochlorothiazide; oral

1.6

6.9

151

960

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

6.9

171

1120

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

6.9

155

992

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

6.9

221

SGA01

NOMESCO Finland

Emergency treatment

1.4

6.9

267

1921

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

6.9

381

2918

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.6

6.9

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

6.9

154

986

-1, ,

ICPC

2.0

6.8

341

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

6.8

363

2760

XF402

NOMESCO Finland

ECG with work load test

1.6

6.8

167

1091

SFA20

NOMESCO Finland

Two-surface restoration

1.3

6.8

1039

9132

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

6.8

362

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

6.8

208

1427

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.8

740

6236

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

6.8

197

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

6.8

105

608

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.8

562

4567

WX213

NOMESCO Finland

Lower leg blockade

3.8

6.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

6.8

615

5060

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

6.8

281

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

6.8

433

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.6

6.8

149

N05CF02

ATC

zolpidem; oral

1.4

6.8

295

2168

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

9.3

6.8

A12BA01

ATC

potassium chloride; oral

1.9

6.8

462

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

6.8

405

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

6.8

370

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.5

6.8

167

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

3.6

6.8

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.3

6.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

6.7

499

IGV01

NOMESCO Finland

Psychiatric network contact

3.1

6.7

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

6.7

1318

11938

-1, ,

NOMESCO Finland

1.3

6.7

582

4759

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

6.7

138

K85

ICD-10 Finland

Acute pancreatitis

2.8

6.7

121

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

6.7

150

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.3

6.7

K91.1

ICD-10 Finland

Postgastric surgery syndromes

22.6

6.7

R03DA04

ATC

theophylline; systemic, rectal

1.8

6.7

560

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

6.6

277

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

6.6

187

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.6

6.6

139

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.6

6.6

145

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

6.6

245

1748

SPAT1153

SPAT

Removal of sutures

1.3

6.6

523

4223

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

6.6

219

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

6.6

175

1165

K29.1

ICD-10 Finland

Other acute gastritis

2.9

6.6

100

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

6.6

438

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.4

6.6

188

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.2

6.6

SPAT1265

SPAT

Breathalyser

3.5

6.6

RD160, ,

NOMESCO Finland

8.7

6.5

U07

ICPC

Urine symptom/complaint other

1.6

6.5

148

950

D01AC02

ATC

miconazole; topical

1.6

6.5

130

808

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

10.0

6.5

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

10.0

6.5

D07AD01

ATC

clobetasol; topical

1.4

6.5

274

2001

TGC00

NOMESCO Finland

Bronchial lavation

2.3

6.5

195

A08

ICPC

Swelling

1.8

6.5

564

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

6.5

214

B50

ICPC

Blood and Immunity, Medication/prescr/renewal

6.9

6.5

R06.4

ICD-10 Finland

Hyperventilation

2.8

6.5

112

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

6.5

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

6.5

234

SPAT1281

SPAT

Other administrative function

1.6

6.5

132

826

X06

ICPC

Menstruation excessive

2.7

6.4

118

P74

ICPC

Anxiety disorder/anxiety state

1.8

6.4

470

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.5

6.4

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.2

6.4

228

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

6.4

281

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

6.4

235

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.1

6.4

255

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

6.4

302

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

6.4

102

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

6.3

351

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

6.3

134

846

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.8

6.3

108

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

6.3

363

2794

Z01.2

ICD-10 Finland

Dental examination

1.3

6.3

822

7070

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

3.2

6.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

6.3

167

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

11.1

6.3

J01MA14

ATC

moxifloxacin; systemic

1.6

6.3

150

975

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.6

6.3

137

D64.8

ICD-10 Finland

Other specified anaemias

2.5

6.3

149

U04

ICPC

Incontinence urine

1.7

6.3

104

616

E50.1

ICD-10 Finland

Vitamin A deficiency with Bitot spot and conjunctival xerosis

+∞

6.3

2682A

ICD-9 Finland

Vitamin D deficiency, Osteomalacia, unspecified[OSTEOMALACIA]

+∞

6.3

E53.0

ICD-10 Finland

Riboflavin deficiency

+∞

6.3

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

6.2

F29

ICPC

Eye symptom/complaint other

1.5

6.2

186

1271

Z31.5

ICD-10 Finland

Genetic counselling

1.8

6.2

527

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

6.2

403

N06AX26

ATC

vortioxetine; oral

1.6

6.2

130

819

L11

ICPC

Wrist symptom/complaint

1.5

6.2

166

1108

A10BD07

ATC

metformin and sitagliptin; systemic

2.0

6.2

340

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.1

6.2

N07BA03

ATC

varenicline; oral

1.9

6.2

426

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

6.1

259

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.3

6.1

194

3AC01, ,

NOMESCO Finland

3.3

6.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.1

521

4242

C01DA14

ATC

isosorbide mononitrate; oral

1.4

6.1

273

2014

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.6

6.1

133

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.1

613

5100

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

6.1

575

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.1

135

862

L04AD01

ATC

ciclosporin; systemic

2.7

6.1

116

D69.0

ICD-10 Finland

Allergic purpura

3.8

6.1

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.1

6.1

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.1

6.1

H04AA01

ATC

glucagon; nasal, parenteral

2.4

6.1

176

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

6.1

229

1639

B01AC04

ATC

clopidogrel; oral

1.4

6.1

267

1966

J01CA08

ATC

pivmecillinam; oral

1.3

6.1

721

6126

IAB11

NOMESCO Finland

Psychiatric mood consultation

8.6

6.1

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

6.1

465

R05

ICPC

Cough

1.3

6.0

431

3425

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.6

6.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

6.0

152

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

6.0

140

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

6.0

138

889

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

6.0

268

A10AB04

ATC

insulin lispro; parenteral

2.1

6.0

248

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.2

6.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

6.0

106

639

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

651

2268

3.71

154.41

7.0

6.0

1.04

mmol/l

0.21

616

2091

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1448

8752

3.12

126.60

11.3

7.1

1.21

mmol/l

1.86

1286

7578

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1358

7995

2.99

123.16

4.4

2.4

66.61

77.83

nmol/l

36.12

1261

7255

(3012095) Magnesium [Moles/volume] in Serum or Plasma

679

2818

3.09

116.64

5.2

3.4

0.79

0.82

mmol/l

7.54

641

2655

(3019309) Folate [Moles/volume] in Red Blood Cells

689

2915

3.03

114.00

2.2

1.7

1181.08

1171.40

nmol/l

0.08

562

2214

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

950

4778

2.81

113.70

3.2

2.3

3.04

2.77

mg/l

2.93

851

4117

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1297

7657

2.82

113.21

3.1

2.1

87.05

95.77

pmol/l

8.24

864

4047

(3024561) Albumin [Mass/volume] in Serum or Plasma

1302

7740

2.80

111.44

7.1

5.0

34.29

35.77

g/l

15.10

1232

7260

(3022948) Iron [Moles/volume] in Serum or Plasma

685

2943

2.97

109.59

3.4

2.6

11.79

13.23

umol/l

5.49

663

2742

(3004789) Transferrin [Mass/volume] in Serum or Plasma

648

2733

2.99

106.82

3.3

2.5

2.30

2.29

g/l

0.07

623

2524

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1296

7810

2.73

105.81

10.1

6.4

1.21

mmol/l

1.95

1224

7214

(3021960) Folate [Moles/volume] in Serum or Plasma

950

5022

2.63

99.62

2.4

1.7

17.40

20.23

nmol/l

7.99

850

4272

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

599

2510

2.94

98.90

3.3

2.6

21.01

23.20

2.97

576

2340

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

400

1340

3.45

96.54

4.8

4.1

91.30

89.64

ng/l

0.12

332

1178

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

968

5514

2.41

82.08

4.1

2.6

56.11

75.90

u/l

0.76

918

5115

(3006653) Thiamine [Moles/volume] in Blood

10.89

81.76

1.6

1.2

131.84

135.66

nmol/l

0.17

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1363

9102

2.43

79.15

9.3

6.4

12.24

11.59

umol/l

0.61

1299

8686

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

417

1628

2.95

76.34

3.2

2.3

0.19

0.21

g/l

8.32

388

1507

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

706

3607

2.44

74.99

2.2

1.7

36672771.34

20865661.87

pmol/l

0.25

589

3005

(3023183) Ammonium ion [Moles/volume] in Plasma

164

351

4.98

72.41

4.5

3.0

34.81

33.89

umol/l

0.15

156

314

(3006315) Basophils [#/volume] in Blood

1333

9032

2.31

71.54

8.7

6.3

0.04

e9/l

0.35

1177

7759

(3013115) Eosinophils [#/volume] in Blood

1360

9324

2.31

70.48

9.1

6.5

0.19

e9/l

0.06

1213

8151

(3001604) Monocytes [#/volume] in Blood

1325

9024

2.28

69.21

8.7

6.2

0.59

0.58

e9/l

0.76

1169

7754

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

909

5341

2.24

68.16

3.3

2.2

214.21

206.12

u/l

0.08

874

5058

(3019198) Lymphocytes [#/volume] in Blood

1341

9233

2.26

67.40

8.7

6.3

1.86

1.92

e9/l

0.81

1213

8148

(3018418) pH of Serum or Plasma

899

5283

2.23

67.12

6.0

4.0

7.40

0.32

715

3816

(3036481) Cortisol [Moles/volume] in Serum or Plasma

404

1663

2.77

66.24

2.4

2.2

369.18

388.85

nmol/l

1.04

373

1543

(3032080) INR in Blood by Coagulation assay

1187

7876

2.17

64.17

18.0

15.3

1.25

1.27

inr

0.48

1028

6603

(3023368) Bacteria identified in Blood by Culture

824

4791

2.19

61.96

5.9

4.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

454

2050

2.55

61.38

3.0

2.7

1.90

1.78

1.39

405

1839

(3020779) Urea [Moles/volume] in Serum or Plasma

372

1522

2.76

61.37

8.6

7.5

9.37

9.66

mmol/l

0.32

354

1468

(3006504) Eosinophils/Leukocytes in Blood

1221

8313

2.12

60.17

8.7

6.4

2.75

2.81

0.42

1156

7794

(3019069) Monocytes/Leukocytes in Blood

1221

8330

2.12

59.62

8.8

6.5

8.80

8.85

0.24

1154

7813

(3013826) Glucose [Moles/volume] in Serum or Plasma

1413

10204

2.18

59.28

8.5

4.9

6.91

6.64

mmol/l

2.81

1368

9643

(3022096) Basophils/Leukocytes in Blood

1215

8308

2.10

58.53

8.8

6.5

0.65

0.68

1.39

1146

7777

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1695

13238

2.47

58.11

13.1

8.0

88.06

79.00

u/l

7.04

1648

12555

(3021447) Carbon dioxide [Partial pressure] in Venous blood

410

1809

2.57

57.87

5.9

3.7

5.83

5.81

kpa

0.18

395

1759

(42870588) Differential panel, method unspecified - Blood

943

5917

2.08

56.76

8.2

6.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1242

8627

2.08

56.53

4.9

3.0

126.34

116.68

ug/l

0.79

1176

8069

(3005719) IgG [Mass/volume] in Serum or Plasma

333

1340

2.77

56.42

3.0

10.38

10.77

g/l

0.97

306

1234

(3037522) Nuclear Ab [Titer] in Serum

494

2415

2.37

55.53

1.5

1.4

470.69

486.11

titre

0.08

116

517

(3018010) Neutrophils/Leukocytes in Blood

1212

8393

2.05

55.00

8.5

6.3

58.04

57.24

1.53

1167

8024

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

288

1087

2.91

54.96

5.5

3.7

5.16

5.12

kpa

0.27

275

1047

(3002030) Lymphocytes/Leukocytes in Blood

1224

8539

2.04

54.01

8.8

6.4

26.84

27.88

2.55

1175

8108

(3009343) pH of Capillary blood

282

1062

2.91

53.99

5.5

3.7

7.41

7.42

0.84

239

897

(3013650) Neutrophils [#/volume] in Blood by Automated count

1389

10150

2.09

53.88

12.6

9.5

4.34

4.06

e9/l

3.59

1250

8828

(3023520) Reticulocytes [#/volume] in Blood

362

1558

2.60

53.47

3.0

2.7

70.52

68.64

e9/l

0.42

283

1135

(3012544) pH of Venous blood

399

1803

2.50

53.18

5.8

3.8

7.37

7.38

1.25

237

1062

(3024354) Oxygen [Partial pressure] in Venous blood

355

1521

2.61

52.88

5.3

3.2

4.51

4.57

kpa

0.21

344

1479

(3015377) Calcium [Moles/volume] in Serum or Plasma

954

6170

2.00

51.23

3.6

3.5

2.32

2.36

mmol/l

9.76

873

5618

(3002032) Base excess in Venous blood by calculation

386

1759

2.46

50.29

5.9

3.7

1.31

1.77

mmol/l

1.25

329

1490

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

554

2973

2.17

48.97

2.4

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

252

942

2.90

48.70

5.2

3.7

1.40

1.73

mmol/l

0.56

197

692

(3020630) Protein [Mass/volume] in Serum or Plasma

330

1422

2.57

48.30

2.4

2.9

65.83

66.55

g/l

0.96

298

1308

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

418

2016

2.34

47.74

3.3

4.4

254.29

248.59

u/l

0.14

406

1924

(3007164) IgA [Mass/volume] in Serum or Plasma

647

3721

2.07

47.44

1.8

1.5

2.63

2.36

g/l

2.43

395

2302

(40768797) Stomach Pathology biopsy report

466

2366

2.25

47.05

1.4

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

304

1292

2.58

45.64

2.2

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

350

1603

2.42

44.72

9.2

7.5

1.60

1.34

mmol/l

2.65

341

1569

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

709

4318

1.97

43.53

1.5

1.3

2.25

1.53

u/ml

0.43

204

1171

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

885

5819

1.90

43.06

4.8

3.2

52.34

32.79

u/l

1.00

836

5528

(3028026) IgM [Mass/volume] in Serum or Plasma

260

1054

2.67

42.83

2.2

1.9

1.32

1.41

g/l

0.28

240

971

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

411

2065

2.23

42.11

2.3

1.8

1.78

1.46

6.29

358

1809

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1602

12880

2.04

40.91

6.2

4.3

14.61

11.80

mm/h

10.12

1513

12022

(3007853) Bacteria identified in Skin by Aerobe culture

404

2044

2.21

40.55

2.1

1.7

—

(3026008) Bacteria identified in Urine by Culture

829

5450

1.86

39.42

4.3

3.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

111

285

4.06

38.69

2.6

1.9

4.49

5.04

mmol/24h

0.99

252

(44816559) Phosphatidylethanol [Mass/volume] in Blood

191

699

2.91

38.10

2.2

1.7

0.46

0.32

mg/l

1.68

326

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

946

6531

1.82

37.97

5.9

3.7

51.99

65.84

ng/l

0.34

723

4485

(3004588) Protein electrophoresis panel - Serum or Plasma

260

1144

2.45

35.85

2.3

2.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1459

11624

1.84

34.87

6.7

4.7

535.17

1957.24

e6/l

1.37

164

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

386

2030

2.11

34.62

5.0

2.8

11.21

8.11

umol/l

0.88

341

1783

(3022313) Gas panel - Capillary blood

194

753

2.74

34.58

5.7

3.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

155

538

3.03

33.92

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

159

561

2.98

33.80

3.2

3.9

71.99

66.05

mg/l

0.08

123

483

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

159

564

2.97

33.48

3.2

3.8

39.21

66.56

mg/l

0.72

124

487

(3004119) Hemoglobin [Mass/volume] in Venous blood

245

1087

2.42

33.07

5.0

3.1

128.19

128.11

g/l

0.02

235

1052

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

198

796

2.64

32.89

1.7

1.9

1.40

1.50

g/l

0.86

169

706

(3007566) Smooth muscle Ab [Titer] in Serum

138

456

3.17

32.84

1.4

1.2

131.11

91.14

titre

0.50

(3026493) Urate [Moles/volume] in Serum or Plasma

674

4349

1.81

32.64

3.2

2.7

346.34

338.06

umol/l

1.02

594

3840

(3000991) Gas panel - Venous blood

313

1550

2.20

32.62

11.0

8.6

—

(3002582) Erythrocytes [#/volume] in Urine

840

5787

1.75

32.46

5.1

3.3

67.08

90.01

e6/l

0.41

698

4413

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

203

834

2.59

32.26

5.4

3.7

49.46

48.42

0.23

198

818

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

166

619

2.83

31.88

2.5

2.2

322.73

407.08

ug/l

0.34

161

586

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

370

1983

2.05

31.28

9.5

7.9

5.00

5.07

kpa

0.54

360

1893

(3027801) Oxygen [Partial pressure] in Arterial blood

370

1984

2.05

31.23

9.5

7.9

11.73

12.45

kpa

2.00

358

1897

(3026782) Osmolality of Urine

553

3430

1.83

30.08

5.0

2.8

538.46

534.83

mosm/kgh2o

0.14

494

3002

(3000850) Epithelial cells [#/volume] in Urine

625

4025

1.79

29.99

3.9

2.6

6.37

5.88

e6/l

0.46

582

3661

(3003396) Base excess in Arterial blood by calculation

363

1964

2.03

29.78

9.6

7.9

0.86

0.93

mmol/l

0.10

302

1586

(3016502) Oxygen saturation in Arterial blood

336

1772

2.07

29.56

9.8

8.3

94.83

95.64

1.37

326

1708

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

142

507

2.93

29.51

3.3

3.7

11.05

3.24

ratio

0.38

285

(3019977) pH of Arterial blood

361

1973

2.00

28.71

9.7

8.0

7.41

7.42

0.38

220

1090

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

208

913

2.42

28.62

1.7

1.5

—

(3019225) pH of Specimen

303

1562

2.10

28.25

5.7

4.2

7.36

7.35

0.59

250

1139

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

396

2249

1.94

28.13

2.3

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

409

2361

1.91

27.61

3.0

2.5

149.72

119.38

ug/g

0.92

334

1909

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

729

5004

1.70

27.37

4.0

3.2

1834.09

1509.86

ng/l

0.85

641

4301

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

121

412

3.06

27.34

1.5

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

449

2687

1.85

27.04

2.7

2.1

29.71

29.57

0.22

424

2612

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

205

917

2.37

27.00

5.1

2.7

0.66

0.62

1.04

205

911

(3042936) Bacteria identified in Isolate by Culture

419

2454

1.88

27.00

2.8

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

230

1082

2.26

26.94

4.0

3.5

4.27

4.51

pmol/l

2.86

204

968

(3000570) Elastase.pancreatic [Mass/mass] in Stool

142

533

2.79

26.89

1.5

259.14

284.31

ug/g

0.58

317

(3044640) Blood type and Crossmatch panel - Blood

806

5713

1.67

26.61

3.4

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

143

543

2.75

26.49

5.9

4.2

1.59

1.51

mg/l

0.55

132

493

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1600

13547

1.77

26.21

6.5

4.4

14.99

14.74

pmol/l

3.55

1484

12482

(1616796) Gas panel - Central venous blood

108

353

3.17

26.15

5.0

3.4

—

(3018095) Leukocytes [#/volume] in Urine

907

6649

1.64

26.09

6.1

3.9

110.35

105.85

e6/l

0.05

715

4652

(3027273) Bicarbonate [Moles/volume] in Venous blood

178

760

2.47

25.97

4.3

3.3

24.71

25.18

mmol/l

0.97

170

729

(3030467) Casts [#/volume] in Urine by Automated count

719

4983

1.67

25.66

4.8

3.2

0.48

0.41

e6/l

0.36

580

3647

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

587

3866

1.72

25.27

2.2

1.7

1.23

mg/l

0.00

461

2954

(3035350) Ketones [Presence] in Urine by Test strip

1193

9422

1.62

24.88

5.9

3.8

22.83

4.20

estimate

0.94

293

1960

(3009508) Creatinine [Moles/volume] in Urine

794

5692

1.64

24.55

4.4

3.4

7.45

7.51

mmol/l

0.12

695

4849

(3021601) Nitrite [Presence] in Urine by Test strip

1181

9322

1.61

24.54

5.9

3.8

0.00

estimate

0.31

290

1927

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

149

604

2.58

24.23

5.7

4.2

24.39

24.74

mmol/l

0.71

133

563

(3017143) Hepatitis C virus Ab [Presence] in Serum

360

2074

1.89

24.18

1.7

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

165

706

2.45

23.93

1.4

1.2

2.13

0.93

u/ml

0.36

(3009261) Glucose [Presence] in Urine by Test strip

1194

9486

1.60

23.84

5.9

3.8

0.00

0.17

estimate

0.53

271

1859

(3033658) Prothrombin time (PT) actual/Normal

645

4432

1.66

23.33

6.9

4.1

87.28

89.16

1.02

625

4337

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

136

537

2.64

23.32

2.4

1.7

0.21

0.23

g/l

1.49

127

508

(3015736) pH of Urine

986

7517

1.59

23.22

4.9

3.4

6.27

6.25

0.22

587

4228

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1405

11671

1.62

22.74

6.0

3.2

72.07

46.10

u/l

5.96

1350

11026

(3002173) Hemoglobin [Mass/volume] in Arterial blood

299

1651

1.95

22.73

10.7

8.9

118.80

120.71

g/l

0.78

292

1606

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

137

554

2.58

22.38

2.4

1.7

1.16

1.17

g/l

0.19

128

522

(3044290) Cell count panel - Cerebral spinal fluid

107

381

2.91

22.34

1.2

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

269

1441

1.99

22.31

4.0

2.4

0.33

0.52

e6/l

1.02

256

1370

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

257

1357

2.02

22.19

5.3

3.5

1.22

1.23

mmol/l

2.31

233

1152

(3023420) DNA double strand Ab [Units/volume] in Serum

166

739

2.35

22.03

2.8

1.9

11.32

7.59

iu/ml

0.49

173

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

147

621

2.47

21.90

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

361

2149

1.82

21.66

2.4

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

138

576

2.49

21.10

2.0

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

159

708

2.35

21.08

2.5

1.9

2.50

1.60

ug/l

0.53

144

624

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

111

419

2.74

20.79

1.2

1.5

3.84

3.73

mmol/l

0.47

397

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

637

2.41

20.72

2.1

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

213

1076

2.09

20.70

2.0

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1042

8190

1.54

20.50

3.6

2.8

—

estimate

—

(3017181) Myelocytes/Leukocytes in Blood

279

1557

1.91

20.44

5.4

4.4

1.24

0.90

1.00

465

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

166

765

2.27

20.31

5.9

5.5

1.61

1.58

0.15

158

713

(3020191) Ethanol [Moles/volume] in Serum or Plasma

140

4.08

20.27

2.3

1.5

1.05

1.07

promille

0.03

111

(3021589) Normoblasts [#/volume] in Blood

1003

7832

1.54

20.24

18.8

11.0

0.00

e9/l

0.93

841

6382

(3029937) Albumin [Presence] in Urine by Test strip

711

5143

1.58

20.21

6.1

3.9

0.00

estimate

1.47

261

1794

(3035637) Corticotropin [Mass/volume] in Plasma

186

3.63

20.20

1.7

20.84

31.16

ng/l

0.91

186

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

118

468

2.61

20.05

1.2

1.5

462.92

510.32

mg/l

0.74

106

447

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

531

3590

1.64

19.94

3.2

2.9

2.44

2.45

mmol/l

0.58

472

3235

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

125

514

2.52

19.72

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1778

15907

1.78

19.51

7.8

5.3

2.09

1.90

mu/l

0.48

1663

14797

(3009445) Proteinase 3 Ab [Units/volume] in Serum

157

720

2.28

19.42

2.0

1.4

9.71

17.43

iu/ml

—

(3020891) Body temperature

166

781

2.22

19.31

5.8

4.1

36.95

36.91

°c

0.83

166

776

(3003181) Sodium [Moles/volume] in Urine

333

2.88

19.23

1.6

1.3

64.85

60.66

mmol/l

0.36

272

(3021440) Promyelocytes/Leukocytes in Blood

265

1486

1.90

19.08

5.6

4.5

0.11

0.01

396

(3017732) Neutrophils [#/volume] in Blood

354

2170

1.76

19.05

3.3

3.1

4.66

4.76

e9/l

0.10

298

1894

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

610

4316

1.58

18.80

3.3

2.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

261

1465

1.89

18.72

5.2

4.3

0.73

0.69

0.11

425

(3020682) Albumin/Creatinine [Ratio] in Urine

720

5308

1.54

18.42

4.6

4.0

14.99

8.70

mg/mmol

1.99

485

3289

(3012516) Albumin [Mass/volume] in Urine

706

5203

1.54

17.99

3.8

3.4

66.95

47.23

mg/l

1.21

490

3311

(3013290) Carbon dioxide [Partial pressure] in Blood

334

2.80

17.99

5.8

3.8

4.82

4.99

kpa

1.52

328

(3027315) Oxygen [Partial pressure] in Blood

334

2.80

17.99

5.8

3.8

8.70

8.60

kpa

0.22

328

(3012501) Base excess in Blood by calculation

334

2.80

17.99

5.8

3.8

2.61

2.51

mmol/l

0.14

220

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

267

3.00

17.50

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

484

3292

1.61

17.41

1.4

1.3

30.05

29.21

iu/ml

0.03

145

998

(3028707) Methadone [Presence] in Urine by Screen method

313

2.82

17.28

4.8

2.6

—

(3025159) Blasts/Leukocytes in Blood

261

1503

1.84

17.21

5.8

4.7

1.53

0.33

0.41

364

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

100

395

2.61

17.15

1.4

1.2

1.43

1.90

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

645

2.24

16.71

2.4

2.5

2.88

2.95

g/l

0.34

124

587

(3019150) Specific gravity of Urine by Refractometry

584

4183

1.55

16.70

5.8

3.9

1.02

1.38

kg/l

0.50

430

2774

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

685

2.20

16.69

2.3

2.4

4.41

4.16

g/l

2.42

130

627

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

685

2.20

16.69

2.3

2.4

7.25

7.30

g/l

0.12

130

627

(3019550) Sodium [Moles/volume] in Serum or Plasma

1879

17272

1.86

16.42

33.8

18.0

139.23

139.63

mmol/l

7.76

1851

16914

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

144

684

2.19

16.35

2.3

2.4

3.94

3.68

g/l

0.65

127

627

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1862

17082

1.81

16.19

29.9

15.5

23.86

24.22

mg/l

0.17

1679

13980

(3010421) pH of Blood

124

556

2.31

16.17

5.5

3.3

7.42

7.41

1.37

124

550

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

120

531

2.34

16.14

3.7

2.8

3.44

3.55

g/l

0.32

114

502

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

900

7101

1.47

15.93

6.1

3.7

0.05

0.07

estimate

0.34

229

1599

(3023103) Potassium [Moles/volume] in Serum or Plasma

1879

17300

1.84

15.93

34.1

18.1

3.95

3.97

mmol/l

2.35

1849

16910

(3021879) Hepatitis B virus core Ab [Presence] in Serum

241

1387

1.83

15.88

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

124

562

2.28

15.78

1.5

0.07

13.36

iu/ml

0.50

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

219

3.08

15.65

1.1

1.59

1.52

g/l

0.65

203

(3028271) Lactate [Moles/volume] in Capillary blood

263

2.88

15.55

3.1

1.8

1.79

1.68

mmol/l

0.34

257

(36660697) Celiac disease serology panel - Serum

256

1511

1.79

15.51

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

493

3452

1.56

15.42

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

143

694

2.14

15.38

5.9

0.90

0.88

0.18

137

644

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

420

2839

1.60

15.27

1.8

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

151

3.51

15.27

1.7

1.1

117.00

107.72

pmol/l

0.55

151

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

450

3098

1.58

15.12

3.9

3.0

1.09

1.03

e6/l

0.18

266

1639

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.25

15.07

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

146

721

2.10

15.01

1.5

1.9

39.09

38.87

u/l

0.05

136

645

(3022145) Colonoscopy Study observation

310

1950

1.69

14.96

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

191

1041

1.92

14.89

7.8

7.0

23.75

24.31

mmol/l

0.95

184

986

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.21

14.87

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

420

2865

1.58

14.63

4.5

3.1

3.57

2.41

e6/l

1.46

227

1409

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

414

2.43

14.63

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

111

500

2.29

14.34

1.5

1.2

3.66

12.91

u/ml

1.40

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

277

1709

1.72

14.33

3.7

2.5

36.09

39.57

u/l

0.34

239

1454

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

129

3.62

14.24

1.2

1.4

2.06

2.00

mmol/l

0.19

124

(3011397) Hemoglobin [Presence] in Urine by Test strip

580

4267

1.50

14.24

5.3

3.7

0.14

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.14

14.21

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

174

3.22

14.14

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

110

497

2.28

14.11

1.5

1.2

1.35

2.71

u/ml

2.23

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

320

2.59

13.93

2.3

2.4

0.86

0.81

nmol/l

0.31

281

(3045414) Leukocytes [Presence] in Urine

270

1668

1.71

13.88

2.3

2.1

0.06

0.01

estimate

0.66

346

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

123

591

2.15

13.58

2.8

2.6

0.34

1.39

g/l

3.82

102

512

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.45

13.56

2.4

4.0

65.25

171.81

umol/l

1.44

(3011288) Drugs identified in Urine by Screen method Nominal

112

519

2.22

13.53

6.4

2.7

—

(3024928) Oxygen saturation in Venous blood

104

468

2.29

13.48

5.4

3.0

60.95

60.64

0.05

455

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

113

529

2.20

13.32

1.5

1.2

37.79

32.70

u/ml

—

(3000012) Reticulocyte production index

248

2.76

13.10

2.2

1.9

0.92

0.86

0.41

171

(3011985) Renin [Units/volume] in Plasma

221

2.86

13.01

1.5

1.4

59.11

47.47

mu/l

0.31

198

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

435

3068

1.53

12.89

1.4

1.3

8.38

9.10

u/ml

0.08

164

1200

(40758558) Short blood count panel - Blood

692

5357

1.44

12.78

8.7

6.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

129

3.46

12.78

1.1

207.97

230.55

mg/l

0.83

108

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

280

1789

1.65

12.63

3.4

4.2

9.18

18.83

ug/l

1.11

232

1463

(3010015) Selenium [Moles/volume] in Serum or Plasma

11.06

12.52

2.1

1.6

1.37

1.25

umol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

445

2.26

12.45

1.9

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

595

2.08

12.23

2.7

2.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

160

878

1.89

12.21

2.6

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

462

2.22

12.19

2.0

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

207

2.85

12.16

1.4

1.3

608.56

330.79

pmol/l

0.59

177

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

100

3.75

12.12

1.8

1.9

95.24

110.71

ng/l

0.51

100

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

282

2.57

12.11

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

107

513

2.14

11.90

2.5

2.4

0.07

0.02

g/l

0.68

461

(3004616) Nuclear Ab [Presence] in Serum

205

2.83

11.79

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

136

3.28

11.79

1.1

1.2

33.05

36.10

mg/l

0.32

110

(3024139) IgG subclass 3 [Mass/volume] in Serum

173

3.00

11.71

1.5

1.3

0.36

0.40

g/l

0.45

126

(3027135) IgG subclass 1 [Mass/volume] in Serum

173

3.00

11.71

1.5

1.3

6.79

6.83

g/l

0.02

126

(3028192) IgG subclass 2 [Mass/volume] in Serum

173

3.00

11.71

1.5

1.3

2.57

2.99

g/l

1.05

126

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1722

15771

1.52

11.71

7.9

5.8

40.18

38.77

mmol/mol

5.96

1608

14784

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.49

11.67

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.49

11.67

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

111

546

2.09

11.56

3.9

3.3

0.31

0.36

iu/ml

1.35

290

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

133

3.28

11.51

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

469

3430

1.47

11.50

5.0

3.9

135.44

411.72

ng/l

5.33

363

2646

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

428

2.23

11.46

1.2

1.7

806.98

559.13

e6/l

0.15

334

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

134

3.26

11.38

1.7

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

423

2.23

11.37

1.2

1.6

18.60

25.51

e6/l

0.19

316

(3006184) Hemoglobin [Mass/volume] in Capillary blood

411

2.24

11.30

3.1

2.1

129.74

129.19

g/l

0.08

333

(3016650) Hepatitis A virus Ab [Presence] in Serum

286

2.50

11.28

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

165

941

1.82

11.15

1.2

1.1

5.85

0.94

u/ml

—

(3016018) Differential panel - Cerebral spinal fluid

195

2.82

11.10

1.2

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

113

573

2.03

10.86

1.4

—

(3037121) Protein [Mass/volume] in Urine

118

608

2.00

10.85

3.3

3.5

336.49

398.57

mg/l

0.21

263

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.66

10.80

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

603

2.00

10.75

2.5

10.54

10.52

g/l

0.02

541

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

183

2.83

10.62

1.1

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

477

2.11

10.52

2.1

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

197

1203

1.70

10.51

1.4

1.3

337.13

200.56

u/ml

0.47

183

1114

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

392

2.22

10.45

1.9

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

187

1128

1.72

10.43

13.4

9.7

93.40

93.93

0.58

187

1122

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

373

2.25

10.42

6.5

5.7

2322.00

473.90

iu/ml

—

(4198724) Urine methamphetamine measurement

3.96

10.31

3.1

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

215

2.65

10.27

1.6

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

176

2.83

10.20

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

167

982

1.76

10.19

14.7

10.7

15.70

15.89

0.34

162

935

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

100

499

2.05

10.06

2.6

2.4

0.00

g/l

-0.00

436

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

321

2.32

10.05

1.9

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

296

2.38

10.04

2.1

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

201

2.68

9.96

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

201

2.68

9.96

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

213

2.62

9.93

1.7

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

261

2.46

9.90

7.2

5.5

355.00

359.84

umol/l

0.09

232

(3045424) Erythrocytes [Presence] in Urine

145

825

1.81

9.89

2.4

2.1

0.00

0.97

estimate

0.50

260

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

157

2.91

9.88

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

202

2.67

9.87

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

115

3.26

9.87

1.5

1.2

26.83

36.09

mmol/l

1.65

106

(3025941) Bacteria identified in Stool by Culture

161

947

1.76

9.81

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

113

595

1.95

9.79

3.8

1.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

225

1454

1.61

9.63

4.2

2.4

5.15

7.33

ug/l

1.99

186

1290

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

194

1211

1.66

9.52

2.4

21.25

19.49

au/ml

0.15

124

(3010375) cycloSPORINE [Mass/volume] in Blood

4.04

9.51

38.7

31.4

123.47

128.82

ug/l

0.12

(3006922) Hepatitis E virus Ab [Presence] in Serum

113

3.22

9.46

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

292

2.34

9.43

1.5

1.7

0.69

0.80

g/l

0.35

227

(4062490) Immunoglobulin typing, IgG

173

2.76

9.37

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

4.38

9.33

1.5

14.67

14.52

pmol/l

0.05

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

339

2.23

9.28

1.7

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

412

2.11

9.25

1.5

1.2

33.13

47.41

u/ml

0.41

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.07

9.25

2.4

1.3

73.38

111.81

nmol/l

0.99

(3024522) Salmonella sp identified in Specimen by Organism specific culture

215

2.55

9.24

1.6

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

188

1175

1.66

9.19

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

347

2.20

9.18

2.2

2.4

139.81

105.56

ug/min

0.30

206

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1741

16183

1.45

9.04

26.8

14.9

82.95

81.58

ml/min/173m2

1.51

1653

14942

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

242

2.44

9.00

1.3

0.16

0.29

nmol/l

—

(3008295) Osmolality of Serum or Plasma

206

2.56

9.00

1.5

1.4

276.57

278.48

mosm/kgh2o

0.24

153

(40768441) Liver Pathology biopsy report

117

3.11

8.95

1.9

1.3

—

(3000494) Fungus identified in Specimen by Culture

299

2094

1.50

8.92

1.8

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

201

2.58

8.92

1.4

1.3

—

nmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

360

2.15

8.79

2.3

3.7

99.58

1130.54

u/ml

0.83

335

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

512

1.96

8.71

2.2

2.1

7.50

15.09

iu/l

0.30

211

(3047181) Lactate [Moles/volume] in Blood

512

1.96

8.71

6.8

1.57

1.34

mmol/l

1.08

441

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

207

1343

1.60

8.71

3.6

3.0

267.84

218.55

ng/l

0.43

185

1227

(3037756) Immunofixation for Serum or Plasma

350

2.16

8.60

1.4

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

126

2.97

8.51

2.1

1.5

24.53

28.45

0.27

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

238

2.39

8.37

1.5

1.3

25.66

24.70

u/l

0.07

196

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

118

3.00

8.20

1.6

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

266

2.29

8.16

1.7

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

108

3.09

8.14

1.1

1.2

0.64

0.55

ratio

0.57

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

112

1911

0.56

8.13

1.8

1.9

3.32

3.42

ratio

0.42

1489

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.77

8.11

1.1

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

270

1888

1.49

8.09

9.2

7.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

119

2.97

8.09

1.6

1.2

—

(3016879) Cocaine [Presence] in Urine

122

704

1.78

7.97

4.0

2.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

2.99

7.93

2.5

2.6

—

(3036489) Thrombin time

117

668

1.80

7.93

3.1

2.3

20.09

20.90

1.50

101

599

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

132

2.84

7.86

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.60

7.85

3.2

2.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

112

633

1.81

7.85

1.8

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

358

2.08

7.76

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

156

2.66

7.73

1.1

—

(3011412) CD3 cells [#/volume] in Blood

156

2.66

7.73

2.6

2.5

1283.66

1215.72

e6/l

0.14

143

(21494890) Protein electrophoresis panel - 24 hour Urine

162

2.63

7.71

1.9

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.45

7.67

1.1

1.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1900

18087

1.54

7.62

36.3

19.7

79.39

76.91

umol/l

1.73

1883

17869

(3014051) Protein [Presence] in Urine by Test strip

625

5088

1.33

7.62

4.2

3.0

0.13

0.04

0.42

113

(44806118) Parainfluenza type 4 nucleic acid detection

236

2.32

7.61

2.1

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

236

2.32

7.61

2.1

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

236

2.32

7.61

2.1

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

236

2.32

7.61

2.1

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

224

2.36

7.58

2.1

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

618

1.81

7.57

1.3

—

(3017569) Oxygen content in Arterial blood

3.18

7.54

1.9

2.5

16.41

16.07

0.22

(3012565) Volume of 24 hour Urine

3.45

7.40

1.9

2.8

2056.75

2087.92

0.05

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

154

2.63

7.38

1.2

1.1

10.17

55.33

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

442

1.94

7.36

1.7

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

271

1933

1.46

7.33

4.7

33.31

32.65

0.35

191

1278

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

215

2.36

7.32

2.3

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

465

1.91

7.28

2.8

2.5

0.00

g/l

-0.00

435

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

203

1368

1.54

7.24

3.9

2.7

62.50

67.56

ml/min/173m2

0.83

114

582

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

327

2.08

7.23

1.5

1.4

123.95

149.28

au/ml

0.76

(3009214) Lutropin [Units/volume] in Serum or Plasma

496

1.87

7.18

1.7

1.5

9.26

9.10

u/l

0.04

390

(3035933) Granulocytes/Leukocytes in Blood

392

1.97

7.06

4.1

3.3

58.91

57.93

0.26

392

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

372

2.00

7.02

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

545

6639

0.76

6.99

3.2

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

126

763

1.69

6.98

3.9

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

118

702

1.72

6.97

3.1

2.1

5568.64

5673.68

u/l

0.01

276

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

197

2.37

6.82

1.3

0.19

0.28

nmol/l

0.43

154

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

4.12

6.81

1.2

1.3

13.19

8.58

pmol/l

—

(3028300) Cannabinoids [Presence] in Urine

126

770

1.68

6.75

4.0

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

620

5121

1.30

6.63

5.4

3.3

0.02

0.08

estimate

0.91

223

1534

(3027008) Opiates [Presence] in Urine

125

766

1.67

6.63

3.9

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

366

1.97

6.63

1.3

251.82

241.29

u/ml

0.15

214

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

244

1739

1.46

6.62

5.5

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

562

1.78

6.59

3.6

2.5

93.52

92.62

0.11

542

(3026389) Candida sp identified in Specimen by Organism specific culture

234

2.21

6.47

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

234

2.21

6.47

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

123

757

1.66

6.43

3.4

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

3.31

6.42

52.5

38.9

6.98

7.17

ug/l

0.16

(21494755) Public health laboratory ask at order entry panel

100

1649

0.59

6.38

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

197

2.31

6.37

2.6

2.4

1.06

1.47

g/24h

0.49

116

(3023410) Appearance of Cerebral spinal fluid

198

2.30

6.30

1.2

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

362

1.94

6.15

1.9

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.77

6.09

1.8

1.7

87.28

665.65

nmol/24h

0.50

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1432

0.57

6.08

1.5

1.7

3.31

3.48

mmol/l

0.71

1002

(3010144) Erythrocytes [#/volume] in Synovial fluid

152

2.46

6.04

2.1

1.4

30535.08

122728.39

e6/l

0.68

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.26

5.92

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

231

2.15

5.84

3.1

2.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.84

5.84

1.5

1.2

102.89

76.40

u/l

0.66

(3042517) Benzodiazepines panel - Urine

11.16

5.79

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.89

5.74

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

6.12

5.69

5.0

2.0

—

(3004775) Volume in Urine collected for unspecified duration

115

2.63

5.65

2.4

578.38

643.05

0.50

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

388

1.86

5.62

1.3

—

56.01

—

(40761511) CBC panel - Blood by Automated count

1840

17570

1.39

5.62

25.5

13.7

—

(3014271) Vancomycin [Susceptibility]

3.12

5.62

3.8

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1868

17886

1.41

5.59

18.9

11.6

26.21

25.50

u/l

0.91

1833

17402

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.82

5.57

1.5

1.2

21.73

18.42

u/l

0.25

(4024509) Urine culture

127

819

1.59

5.54

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.09

5.43

1.1

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.97

5.42

4.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1711

16193

1.31

5.30

5.8

4.8

6.06

5.85

mmol/l

5.59

1578

14876

(3000034) Microalbumin [Mass/volume] in Urine

133

2.43

5.14

4.1

2.7

153.30

24.25

mg/l

0.84

(3002079) Sodium [Moles/time] in 24 hour Urine

3.02

5.10

1.4

1.3

135.95

169.50

mmol/24h

1.25

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

13.38

5.08

4.3

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.10

5.07

1.5

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

106

670

1.61

5.05

3.0

3.4

1177.16

6128.64

u/ml

0.63

583

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.78

5.04

1.9

1.5

0.72

1.14

nmol/l

1.93

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.42

5.03

3.2

2.7

0.59

0.62

mmol/l

0.70

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.71

5.01

1.0

1.1

1386.36

1625.62

miu/ml

0.45

(3006270) Folate [Moles/volume] in Blood

141

2.36

5.00

1.3

1.1

399.46

386.69

nmol/l

0.11

126

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

179

1272

1.45

4.96

1.3

1.2

273.96

137.92

u/ml

1.10

498

(3028308) Erythrocytes [#/volume] in Pleural fluid

180

2.19

4.95

1.2

1.4

99280.91

63513.88

e6/l

0.18

(3016750) Collection duration of Urine

2.75

4.94

2.2

503.18

497.47

min

0.08

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.68

4.92

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

2.52

4.88

3.0

2.6

579.90

559.87

e6/l

0.05

(3042111) Morphology [Interpretation] in Bone marrow Narrative

298

1.90

4.86

1.8

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

492

1.69

4.79

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

5.23

4.77

1.3

1.2

58.23

67.20

ug/l

0.52

(3006571) Granulocytes/Leukocytes in Synovial fluid

183

2.15

4.76

1.6

67.85

62.14

0.45

119

(3044927) Protein electrophoresis panel - Urine

177

2.17

4.73

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

114

2.48

4.71

3.1

2.7

172.18

220.02

e6/l

0.63

102

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

266

1.94

4.70

1.1

56.98

2275.82

iu/ml

0.53

(1761482) Bacteria [#/volume] in Urine by Culture

383

1.77

4.65

8.8

4.6

—

(3012441) Differential panel - Pleural fluid

172

2.17

4.63

1.2

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

497

1.68

4.62

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

101

647

1.59

4.58

1.7

1.6

12.53

11.18

u/ml

0.14

158

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

491

1.68

4.57

1.3

1.2

—

(3017704) Immunofixation for Urine

104

2.52

4.55

1.7

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

208

2.04

4.48

1.3

1.4

1508.20

1565.73

e6/l

0.04

140

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.94

4.44

1.1

1.6

80.86

88.14

0.38

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

125

2.34

4.34

1.2

1.4

19.50

22.09

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

197

2.05

4.34

1.6

1.5

318.38

328.74

mu/l

0.13

161

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.22

4.33

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.90

4.33

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.27

4.29

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

139

2.25

4.25

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

139

2.25

4.25

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

139

2.25

4.25

1.4

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

264

1.88

4.14

4.3

4.2

1.38

1.67

0.32

241

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

136

2.22

4.02

2.5

2.1

2.24

1.73

u/field

0.32

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

130

2.25

4.00

2.0

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

143

2.19

3.99

1.4

1.5

17.59

12.45

umol/l

1.72

133

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.03

3.96

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.03

3.96

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

198

1.99

3.93

2.2

26.65

18.73

mg/l

0.62

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

170

1250

1.39

3.93

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.80

3.87

1.0

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

2.78

3.85

1.4

1.3

5.80

4.06

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

3.85

1.1

1.2

82.08

87.11

0.37

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.98

3.85

1.4

9.59

13.15

g/l

0.89

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.98

3.85

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.96

3.79

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

509

1.59

3.78

3.6

3.4

1.83

2.93

index

0.60

266

(3007463) Buprenorphine [Presence] in Urine

12.03

3.76

4.2

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

161

2.07

3.71

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.52

3.71

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

2.28

3.71

1.0

1.1

1.20

1.10

u/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

267

0.33

3.69

1.6

1.7

—

(40761536) Microorganisms panel - Urine sediment

188

1425

1.35

3.62

6.2

3.9

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.52

3.60

1.1

1.3

83.89

76.45

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.52

3.60

1.1

1.3

79.78

65.36

—

(3024869) Neuronal Ab [Presence] in Serum

4.02

3.59

1.3

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.76

3.59

1.1

46.80

254.33

ng/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.41

3.56

2.7

2.4

1334.09

993.20

u/ml

0.37

(3039000) Anion gap in Blood by calculation

354

1.69

3.53

8.8

8.3

12.31

11.42

mmol/l

0.96

314

(40768804) Tissue Pathology biopsy report

779

6967

1.19

3.51

2.3

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

214

1.89

3.50

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

355

1.68

3.50

8.8

8.2

104.31

105.01

mmol/l

0.41

315

(3004451) EKG impression Narrative

2.43

3.47

1.2

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.56

3.43

1.2

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

381

1.65

3.40

1.5

1.3

—

(21494434) Karyotype in Bone marrow

160

2.02

3.40

1.2

—

(3022689) Creatine [Moles/volume] in Urine

3.11

3.37

1.5

1.3

6.33

8.20

mmol/l

0.79

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

101

2.29

3.36

1.1

1.10

1.05

ratio

0.58

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.84

3.36

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.84

3.36

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.84

3.36

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.84

3.36

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.73

3.34

1.0

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

253

2025

1.28

3.31

2.1

—

(3028433) Virus identified in Specimen by Culture

2.93

3.30

1.4

1.3

—

(3024932) HLA-DR beta [Type]

2.93

3.30

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

126

910

1.41

3.27

1.6

1.4

22.05

27.45

iu/l

1.07

103

772

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.79

3.25

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

129

2.11

3.24

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.45

3.21

1.1

—

(3024471) HLA-A [Type]

2.87

3.19

1.0

—

(3042733) HLA Ab [Presence] in Serum

2.87

3.19

2.7

4.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

104

2.22

3.16

1.9

2.2

9.65

7.83

mmol/l

0.54

104

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

151

2.00

3.15

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.64

3.13

1.6

2.2

27.44

29.82

0.25

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

495

1.53

3.09

1.1

3.59

4.03

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.24

3.06

1.4

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

7.52

3.05

2.3

3.1

1.25

4.76

mg/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

174

1.91

3.05

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.44

3.05

1.1

222.79

211.75

iu/ml

0.07

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1191

11115

1.17

3.01

3.4

3.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.56

2.99

1.8

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

540

1.50

2.98

1.4

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.02

2.98

1.0

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

435

1.56

2.98

2.3

1.7

16698.08

13824.16

e6/l

0.18

305

(40757373) Influenza virus identified in Isolate

3.26

2.93

2.1

1.8

—

(3045788) Cell count panel - Pleural fluid

177

1.88

2.91

1.1

1.4

—

(4146454) Self-monitoring of blood glucose

142

1.99

2.90

2.1

2.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.10

2.88

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.10

2.88

1.1

1.0

—

(3008898) HLA-B27 [Presence]

644

1.45

2.87

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

102

2.17

2.87

2.0

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

653

1.44

2.86

1.6

310.12

307.36

mu/l

0.02

589

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

241

2944

0.80

2.85

3.2

0.82

0.77

ug/l

0.31

172

1892

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

269

2212

1.25

2.83

2.2

—

(3022621) pH of Urine by Test strip

181

1419

1.30

2.80

3.4

2.5

6.11

6.10

0.07

125

958

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.47

2.79

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

126

938

1.37

2.77

3.1

3.4

106.64

74.31

u/ml

0.26

121

909

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

492

1.50

2.76

1.1

11.73

5.47

eliau/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

385

3295

1.21

2.75

1.8

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.35

2.75

3.6

4.7

100.40

99.00

g/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.72

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

2.72

4.4

2.9

0.05

0.18

e9/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.15

2.71

2.0

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.01

2.70

1.5

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.15

2.64

1.3

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

106

2.09

2.63

1.7

1.5

—

(44813793) Dust mix specific IgE antibody measurement

113

2.05

2.62

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.56

2.61

1.7

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.68

2.59

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

1909

18636

1.28

2.58

43.9

23.4

255.53

251.46

e9/l

1.61

1878

18279

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1909

18640

1.27

2.55

43.7

23.3

91.33

91.04

1.56

1891

18444

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1634

15717

1.18

2.55

4.6

4.1

1.40

1.24

mmol/l

9.72

1505

14490

(3035941) MCH [Entitic mass]

1909

18643

1.27

2.52

43.6

23.2

30.27

30.31

0.36

1891

18446

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1909

18643

1.27

2.52

45.1

23.8

38.86

40.37

7.23

1889

18435

(3026361) Erythrocytes [#/volume] in Blood

1909

18643

1.27

2.52

43.8

23.3

4.32

4.47

e12/l

24.47

1875

18236

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.24

2.51

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.47

2.48

2.1

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

4.39

2.47

1.0

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

144

1.89

2.46

3.1

2.5

46.17

38.69

1.54

144

(3010813) Leukocytes [#/volume] in Blood

1909

18650

1.27

2.46

43.9

23.4

7.05

6.74

e9/l

5.56

1874

18236

(3000963) Hemoglobin [Mass/volume] in Blood

1909

18650

1.27

2.46

44.3

23.5

129.58

134.45

g/l

34.47

1890

18455

(3023419) Bacteria identified in Sputum by Culture

233

1.69

2.46

2.2

3.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

174

1.79

2.42

4.4

3.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

1.99

2.35

2.0

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.83

2.34

1.0

1.6

—

(3000330) Specific gravity of Urine by Test strip

114

863

1.34

2.30

6.8

3.5

1.02

ratio

1.38

109

775

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1506

14433

1.15

2.30

34.3

19.0

13.98

13.59

20.53

1497

14236

(3044007) Cell count panel - Peritoneal fluid

2.46

2.27

2.7

2.2

—

(3049717) Cytology report of Urine Cyto stain

649

1.39

2.27

2.0

2.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.63

2.27

1.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.49

2.27

1.0

1.1

—

(40768443) Skin Pathology biopsy report

104

779

1.35

2.25

1.3

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

142

1.84

2.23

2.3

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1738

16854

1.18

2.22

6.0

5.5

2.56

2.72

mmol/l

10.44

1620

15709

(3033099) Centromere Ab [Titer] in Serum

3.11

2.22

1.0

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

187

1.72

2.21

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.87

2.20

1.1

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.69

2.20

1.9

2.3

14.19

16.46

umol/l

0.30

(4268621) Lupus anticoagulant assay

180

1.73

2.19

2.4

2.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.34

2.18

2.4

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

519

1.42

2.17

2.5

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1714

16611

1.18

2.17

5.4

4.8

4.43

4.64

mmol/l

13.56

1598

15565

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.29

2.15

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

339

1.52

2.12

1.0

1.1

14.81

15.73

au/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

197

1.69

2.12

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

631

0.64

2.12

1.0

1.1

0.51

0.64

ratio

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

244

1.61

2.10

4.8

2.0

19.78

6.53

umol/l

0.91

178

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

244

1.61

2.10

1.1

1.2

113.97

117.32

0.23

225

(3004716) Salmonella sp identified in Stool by Organism specific culture

117

903

1.31

2.09

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.57

2.08

1.0

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1703

16510

1.17

2.08

5.3

4.8

1.41

1.48

mmol/l

10.00

1580

15362

(3026480) Teichoate Ab [Titer] in Serum

5.01

2.07

1.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

124

1.86

2.07

1.2

1.1

0.10

4.22

nmol/l

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.08

2.07

1.5

1.6

—

1012591.50

—

(3052592) Norovirus Ag [Presence] in Stool

3.08

2.01

1.0

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

868

0.71

1.99

1.5

1.6

945.73

1057.54

mu/l

0.45

729

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.29

1.97

1.8

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.09

1.96

2.1

4.2

1.13

1.18

0.07

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

1.96

3.0

2.9

0.57

0.76

u/field

—

(4195642) Thrombophilia screening test

233

1.60

1.96

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

273

1.55

1.95

1.2

2.75

3.80

u/ml

0.36

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

498

0.62

1.95

1.6

1.5

48.61

61.98

ug/l

1.28

416

(3020491) Glucose [Moles/volume] in Blood

105

1.91

1.95

2.2

1.7

7.23

6.64

mmol/l

0.25

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

678

0.67

1.95

1.0

1.1

1.53

1.55

g/l

0.17

678

(3025549) Creatine [Moles/time] in 24 hour Urine

4.55

1.94

1.0

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

4.55

1.94

1.4

1.6

2.14

1.72

nmol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.97

1.93

2.1

2.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.76

1.93

1.2

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

365

1.46

1.89

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

365

1.46

1.89

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.19

1.88

1.0

1.1

0.40

0.02

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

144

1.75

1.85

2.2

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

167

1.69

1.84

4.6

5.1

80.81

67.02

u/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

3.54

1.84

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

632

1.34

1.82

1.6

3.99

3.97

mg/l

0.01

446

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.17

1.82

6.2

5.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.17

1.82

1.2

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

145

1.73

1.81

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

184

1.64

1.79

1.2

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

362

1.45

1.78

3.1

3.5

0.87

0.83

nmol/l

0.16

298

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

1.75

1.1

—

(3019174) dRVVT (LA screen)

3.34

1.74

1.3

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

1.74

6.2

4.3

18.22

28.27

mg/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.23

1.74

2.0

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.85

1.71

2.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

394

0.60

1.69

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

149

1.69

1.67

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.16

1.66

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.81

1.65

2.0

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.81

1.65

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

1.93

1.64

1.8

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

150

1.67

1.63

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.67

1.63

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

105

1.82

1.63

1.9

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

105

1.82

1.63

1.9

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

311

1.46

1.62

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.15

1.61

1.3

1.8

41.08

40.26

g/l

0.20

(3044941) Cell count panel - Synovial fluid

312

1.45

1.59

2.0

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.07

1.59

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

752

7008

1.11

1.59

2.1

1.9

1.45

1.31

mmol/l

3.57

649

5979

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.01

1.59

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

387

0.62

1.59

1.6

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.01

1.58

1.5

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.83

1.57

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.0

—

(3005033) Fetal Nuchal fold Thickness US

379

0.63

1.47

1.6

1.5

1.34

1.28

0.30

271

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

109

1.75

1.46

1.7

2.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

462

0.67

1.46

1.5

0.99

1.14

ratio

0.43

283

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

462

0.67

1.46

1.5

1.06

1.22

ratio

0.56

283

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

462

0.67

1.46

1.5

0.97

0.96

ratio

0.04

283

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

294

1.44

1.5

1.3

70.76

33.71

u/l

0.57

252

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.13

1.44

3.4

2.4

0.80

0.69

ug/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.61

1.43

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

110

1.73

1.43

1.0

250.71

316.49

ng/l

0.91

(3018333) Ribosomal P Ab [Presence] in Serum

141

1.64

1.41

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.26

1.40

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

111

1.72

1.39

1.0

882.00

693.97

ng/l

1.43

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

111

1.72

1.39

1.0

23.73

44.35

ng/l

3.10

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

455

0.68

1.37

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

284

1.42

1.30

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

1.59

1.29

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.78

1.28

4.0

2.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

448

1.33

1.28

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

268

1.43

1.28

1.3

1.2

3.75

5.28

u/ml

0.48

123

(3003740) Influenza virus B Ag [Presence] in Specimen

341

0.64

1.27

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

341

0.64

1.27

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.01

1.27

3.2

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.40

1.24

1.0

1.6

—

(4035726) Immunohistochemistry procedure

171

1470

1.18

1.24

1.5

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.86

1.24

1.0

1.1

94.14

90.75

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

1.54

1.23

3.7

5.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.11

1.18

3.5

1.9

0.23

0.13

nmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

275

1.39

1.13

1.0

1.1

4.60

5.47

u/ml

0.09

124

(40768446) Kidney Pathology biopsy report

1.85

1.13

1.4

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.12

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

1.12

1.9

1.3

1.14

1.18

mmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

285

1.38

1.11

1.1

—

1.44

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

253

1.39

1.06

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.96

1.03

1.0

1.3

—

(44806071) Cardiolipin IgM antibody measurement

2.28

1.03

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.28

1.03

1.4

1.0

76.80

75.64

titre

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.06

1.03

4.6

7.4

4.94

5.25

kpa

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

359

1.32

1.02

1.1

6.73

5.39

u/ml

0.29

205

(3045142) Bone marrow Pathology biopsy report

213

1.41

1.02

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

188

1.44

1.01

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

413

1.29

1.00

1.1

2.80

2.67

u/ml

0.03

229

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

369

1.31

1.00

2.3

1.9

174.81

212.24

pmol/l

1.71

352

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.00

3.1

3.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.81

0.98

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.18

0.98

1.4

1.2

1.72

1.75

umol/24h

—

(4281824) Cell count and differential, peritoneal fluid

190

1.43

0.97

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

100

1.60

0.96

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

182

1.43

0.96

5.2

3.4

13.70

11.62

index

0.55

107

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

199

1.41

0.95

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.95

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.95

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.95

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.95

1.6

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

208

1.40

0.94

2.3

2.5

—

42.62

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

617

1.22

0.92

1.2

1.3

276.86

225.17

miu/ml

0.40

298

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

142

1.48

0.92

1.3

2.45

2.25

u/ml

0.03

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

142

1.48

0.92

1.4

2.0

4.55

3.83

mg/l

0.24

137

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

978

1.18

0.90

1.1

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

0.01

0.16

u/ml

—

(40768800) Prostate Pathology biopsy report

312

0.70

0.88

1.0

1.2

—

(4211845) Urine protein measurement

1.65

0.88

4.5

2.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

246

1.35

0.87

1.8

1.4

3.06

3.48

ug/l

0.21

221

(3003694) ABO and Rh group [Type] in Blood

537

5057

1.08

0.87

1.5

—

(3014891) Appearance of Pleural fluid

2.00

0.87

1.8

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

148

1305

1.14

0.83

2.7

2.3

12.09

13.05

nmol/l

0.65

136

1191

(3002256) Pathology report gross observation

253

2306

1.11

0.83

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

257

1.33

0.83

1.0

1.1

6.17

2.23

eliau/ml

—

119

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.88

0.81

1.2

—

216.40

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

347

1.27

0.80

1.1

1.82

1.60

u/ml

0.07

160

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.73

0.79

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.73

0.79

1.7

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

277

1.30

0.79

1.4

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.51

0.78

1.4

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

123

1.47

0.77

2.0

1.4

87.89

79.81

umol/l

0.52

123

(3050129) First trimester maternal screen panel - Serum or Plasma

550

0.80

0.77

1.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.70

0.75

1.7

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

297

1.28

0.75

1.0

1.1

0.49

2.86

u/ml

4.41

151

(21491868) Cryoglobulin [Mass/volume] in Serum

1.65

0.75

1.1

—

0.11

g/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.09

0.74

14.4

12.0

6.16

5.95

mmol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

1.50

0.73

6.5

7.1

4.30

192.32

ug/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.62

0.71

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.85

0.68

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.67

0.68

1.0

1.1

3.77

6.63

u/ml

—

(40768793) Breast Pathology biopsy report

452

0.79

0.68

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.79

0.66

1.6

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

128

0.62

0.64

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.73

0.64

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

619

0.84

0.61

1.4

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.03

—

(3019832) Treponema pallidum Ab [Presence] in Serum

206

1897

1.10

0.59

1.7

1.8

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.00

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.51

0.58

1.3

1.4

9.94

9.12

ug/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.51

0.58

1.3

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.51

0.58

3.5

2.8

8.10

10.47

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.51

0.58

3.5

2.8

4.41

4.73

kpa

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

365

0.79

0.58

1.9

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.72

0.57

1.0

1.5

—

(3005570) Glucose [Moles/volume] in Urine

176

1.31

0.56

2.7

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

185

1.30

0.56

1.1

1.4

6.93

6.54

mmol/l

0.36

175

(3010726) Horse dander IgE Ab [Units/volume] in Serum

349

1.21

0.54

1.1

2.94

1.70

u/ml

0.27

182

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

292

0.79

0.51

3.3

4.2

16.26

31.21

u/ml

2.43

287

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

378

3974

0.94

0.50

4.2

4.5

21.93

21.66

0.12

179

1926

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

312

0.80

0.49

1.3

1.5

46.58

60.77

ug/l

1.77

312

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

119

1.35

0.48

1.4

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

263

1.22

0.47

1.0

0.05

0.33

u/ml

1.61

(3024263) Appearance of Synovial fluid

1.41

0.43

3.7

1.7

—

(3006462) Nitrate [Presence] in Urine

1.43

0.41

5.4

2.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1437

14566

0.96

0.41

35.3

19.9

330.80

332.29

g/l

6.98

1427

14476

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.52

0.41

2.0

3.2

3.40

6.00

ug/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.01

—

(3001019) Free T4 and TSH panel - Serum or Plasma

918

0.90

0.40

1.7

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.23

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

410

0.85

0.39

1.5

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.32

0.37

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

147

0.75

0.37

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

0.70

0.37

1.0

—

(4015189) Microbial culture of sputum

1.40

0.35

2.2

2.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

233

0.81

0.34

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

188

1990

0.94

0.34

1.6

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

109

1.29

0.33

1.0

1.1

2.14

0.86

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

145

1361

1.07

0.32

2.6

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

351

1.14

0.32

3.7

3.6

34.19

28.31

mg/l

0.42

249

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.72

0.31

1.3

1.4

182.63

160.18

pmol/l

—

(1002224) Polysomnography panel

798

1.08

0.27

1.1

—

(40768795) Lymph node Pathology biopsy report

178

1.18

0.26

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.32

0.23

2.8

3.3

42.00

45.53

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.32

0.23

5.6

6.5

7.60

8.82

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

505

0.91

0.23

1.3

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

45.00

—

(4034850) Laboratory test

527

1.08

0.21

10.4

10.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.07

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

4.74

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.21

0.19

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.19

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

241

1.12

0.19

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.24

0.18

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.13

0.18

1.3

1.6

—

(40765096) Chromosome analysis panel by Banding

1.13

0.17

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

582

1.07

0.17

1.6

1.5

—

(3025130) Human papilloma virus identified in Specimen

295

1.09

0.14

1.6

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

500

4931

1.02

0.12

4.9

5.5

2.08

3.03

ug/l

2.51

442

4436

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

117

1131

1.04

0.12

2.3

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

1.14

0.11

1.6

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.14

0.10

1.0

6.74

34.36

iu/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.82

0.08

1.0

—

(3020650) Glucose [Presence] in Urine

1.08

0.08

2.6

2.1

0.00

estimate

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.03

0.07

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

215

1.07

0.07

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.05

0.07

1.3

1.2

12.88

9.17

mm/h

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.85

0.06

1.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

129

1.09

0.05

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

151

1.06

0.03

1.2

1.1

70.54

15.47

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

102

1.08

0.03

1.0

1.80

2.85

u/ml

—

(44806420) Estimation of glomerular filtration rate

187

0.96

0.01

2.7

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

437

0.98

0.01

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

286

2855

1.00

0.00

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

318

1.01

0.00

1.4

0.24

0.33

nmol/l

0.98

249

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

10.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1765.20

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.01

-0.00

1.0

1.5

0.44

0.48

e9/l

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.91

-0.00

1.0

1.6

17.97

33.45

nmol/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

0.43

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.95

-0.00

1.1

1.6

—

1952.31

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.96

-0.00

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.88

-0.00

1.4

1.1

106.02

45.31

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.6

—

6.85

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

110

1.00

-0.00

1.0

2.75

0.74

u/ml

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_VIT_DEF – Vitamin deficiency

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Vitamin deficiency

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Vitamin deficiency (E4_VIT_DEF)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints